SEARCH

SEARCH BY CITATION

References

  • 1
    Bouchard, C., Perusse, L. (1996) Current status of the human obesity gene map. Obes Res. 4: 8190.
  • 2
    Perusse, L., Bouchard, C. (1996) Identification of genes contributing to excess body fat and fat distribution. In: Angel, A Anderson, H Bouchard, C Lau, D Leiter, L and Mendelson, R (eds). 7th International Congress on Obesity. Progress in Obesity Research 7. John Libbey & Company Ltd Toronto. 281289.
  • 3
    Perusse, L., Chagnon, Y. C., Dionne, F. T., Bouchard, C. (1997) The human obesity gene map: the 1996 update. Obes Res. 5: 4961.
  • 4
    Chagnon, Y. C., Perusse, L., Bouchard, C. (1998) The human obesity gene map: the 1997 update. Obes Res. 6: 7692.
  • 5
    Perusse, L., Chagnon, Y. C., Weisnagel, J., Bouchard, C. (1999) The human obesity gene map: the 1998 update. Obes Res. 7: 111129.
  • 6
    Chagnon, Y. C., Perusse, L., Weisnagel, J. S., Rankinen, T., Bouchard, C. (2000) The human obesity gene map: the 1999 update. Obes Res. 8: 89117.
  • 7
    Perusse, L., Chagnon, Y. C., Weisnagel, S. J., et al (2001) The human obesity gene map: the 2000 update. Obes Res. 9: 135169.
  • 8
    Rankinen, T., Perusse, L., Weisnagel, S. J., Snyder, E. E., Chagnon, YC. (2002) Bouchard C. The human obesity gene map: the 2001 update. Obes Res. 10: 196243.
  • 9
    Chagnon, Y. C., Rankinen, T., Snyder, E. E., Weisnagel, S. J., Perusse, L. (2003) Bouchard C. The human obesity gene map: the 2002 update. Obes Res. 11: 313367.
  • 10
    Walsh, S., Anderson, M., Cartinhour, SW. (1998) ACEDB: a database for genome information. Methods Biochem Anal. 39: 299318.
  • 11
    Kelley, S. (2000) Getting started with Acedb. Brief Bioinform. 1: 131137.
  • 12
    Waterston, R., Sulston, J. (1995) The genome of Caenorhabditis elegans. Proc Natl Acad Sci U S A. 92: 1083610840.
  • 13
    Thorisson, G. A., Stein, LD. (2003) The SNP Consortium website: past, present and future. Nucleic Acids Res. 31: 124127.
  • 14
    Stein, L. D., Thierry-Mieg, J. (1998) Scriptable access to the Caenorhabditis elegans genome sequence and other ACEDB databases. Genome Res. 8: 13081315.
  • 15
    Antonarakis, SE. (1998) Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat. 11: 13.
  • 16
    Gene Ontology Consortium. (2001) Creating the gene ontology resource: design and implementation. Genome Res. 11: 14251433.
  • 17
    Farooqi, I. S., Keogh, J. M., Yeo, G. S., Lank, E. J., Cheetham, T., O'Rahilly, S. (2003) Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 348: 10851095.
  • 18
    Hebebrand, J., Fichter, M., Gerber, G., et al (2002) Genetic predisposition to obesity in bulimia nervosa: a mutation screen of the melanocortin-4 receptor gene. Mol Psychiatry. 7: 647651.
  • 19
    Hinney, A., Hohmann, S., Geller, F., et al (2003) Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J Clin Endocrinol Metab. 88: 42584267.
  • 20
    Marti, A., Corbalan, M. S., Forga, L., Martinez, J. A., Hinney, A., Hebebrand, J. (2003) A novel nonsense mutation in the melanocortin-4 receptor associated with obesity in a Spanish population. Int J Obes Relat Metab Disord. 27: 385388.
  • 21
    Tao, Y. X., Segaloff, DL. (2003) Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity. Endocrinology. 144: 45444551.
  • 22
    Yeo, G. S., Lank, E. J., Farooqi, I. S., Keogh, J., Challis, B. G., O'Rahilly, S. (2003) Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum Mol Genet. 12: 561574.
  • 23
    Nijenhuis, W. A., Garner, K. M., van Rozen, R. J., Adan, RA. (2003) Poor cell surface expression of human melanocortin-4 receptor mutations associated with obesity. J Biol Chem. 278: 2293922945.
  • 24
    Lubrano-Berthelier, C., Cavazos, M., Dubern, B., et al (2003) Molecular genetics of human obesity-associated MC4R mutations. Ann N Y Acad Sci. 994: 4957.
  • 25
    Branson, R., Potoczna, N., Kral, J. G., Lentes, K. U., Hoehe, M. R., Horber, FF. (2003) Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med. 348: 10961103.
  • 26
    Challis, B. G., Pritchard, L. E., Creemers, J. W., et al (2002) A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet. 11: 19972004.
  • 27
    Savage, D. B., Agostini, M., Barroso, I., et al (2002) Digenic inheritance of severe insulin resistance in a human pedigree. Nat Genet. 31: 379384.
  • 28
    Mantovani, G., Romoli, R., Weber, G., et al (2000) Mutational analysis of GNAS1 in patients with pseudohypoparathyroidism: identification of two novel mutations. J Clin Endocrinol Metab. 85: 42434248.
  • 29
    Ahrens, W., Hiort, O., Staedt, P., Kirschner, T., Marschke, C., Kruse, K. (2001) Analysis of the GNAS1 gene in Albright's hereditary osteodystrophy. J Clin Endocrinol Metab. 86: 46304634.
  • 30
    Linglart, A., Carel, J. C., Garabedian, M., Le, T., Mallet, E., Kottler, ML. (2002) GNAS1 lesions in pseudohypoparathyroidism Ia and Ic: genotype phenotype relationship and evidence of the maternal transmission of the hormonal resistance. J Clin Endocrinol Metab. 87: 189197.
  • 31
    Lim, S. H., Poh, L. K., Cowell, C. T., Tey, B. H., Loke, KY. (2002) Mutational analysis of the GNAS1 exons encoding the stimulatory G protein in five patients with pseudohypoparathyroidism type 1a. J Pediatr Endocrinol Metab. 15: 259268.
  • 32
    Rickard, S. J., Wilson, LC. (2003) Analysis of GNAS1 and overlapping transcripts identifies the parental origin of mutations in patients with sporadic Albright hereditary osteodystrophy and reveals a model system in which to observe the effects of splicing mutations on translated and untranslated messenger RNA. Am J Hum Genet. 72: 961974.
  • 33
    Phelan, M. C., Rogers, R. C., Clarkson, K. B., et al (1995) Albright hereditary osteodystrophy and del(2) (q37.3) in four unrelated individuals. Am J Med Genet. 58: 17.
  • 34
    Wilson, L. C., Leverton, K., Oude Luttikhuis M. E., et al (1995) Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localized to 2q37. Am J Hum Genet. 56: 400407.
  • 35
    Davids, M. S., Crawford, E., Weremowicz, S., et al (2001) STK25 is a candidate gene for pseudopseudohypoparathyroidism. Genomics. 77: 24.
  • 36
    Schmidt, H. H., Genschel, J., Baier, P., et al (2001) Dyslipemia in familial partial lipodystrophy caused by an R482W mutation in the LMNA gene. J Clin Endocrinol Metab. 86: 22892295.
  • 37
    Garg, A., Speckman, R. A., Bowcock, AM. (2002) Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene. Am J Med. 112: 549555.
  • 38
    van der Kooi, A. J., Bonne, G., Eymard, B., et al (2002) Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. Neurology. 59: 620623.
  • 39
    Caux, F., Dubosclard, E., Lascols, O., et al (2003) A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab. 88: 10061013.
  • 40
    Hegele, R. A., Cao, H., Frankowski, C., Mathews, S. T., Leff, T. (2002) PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes. 51: 35863590.
  • 41
    Savage, D. B., Tan, G. D., Acerini, C. L., et al (2003) Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes. 52: 910917.
  • 42
    Heon, E., Greenberg, A., Kopp, K. K., et al (2002) VSX1: a gene for posterior polymorphous dystrophy and keratoconus. Hum Mol Genet. 11: 10291036.
  • 43
    Wollnik, B., Kayserili, H., Uyguner, O., Tukel, T., Yuksel-Apak, M. (2002) Haploinsufficiency of TBX3 causes ulnar-mammary syndrome in a large Turkish family. Ann Genet. 45: 213217.
  • 44
    Amor, DJ. (2002) Morbid obesity and hyperphagia in the WAGR syndrome. Clin Dysmorphol. 11: 7374.
  • 45
    Chao, L. Y., Mishra, R., Strong, L. C., Saunders, GF. (2003) Missense mutations in the DNA-binding region and termination codon in PAX6. Hum Mutat. 21: 138145.
  • 46
    Groussin, L., Jullian, E., Perlemoine, K., et al (2002) Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab. 87: 43244329.
  • 47
    Stergiopoulos, S. G., Stratakis, CA. (2003) Human tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease!. FEBS Lett. 546: 5964.
  • 48
    Stratakis, CA. (2001) Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes. J Endocrinol Invest. 24: 370483.
  • 49
    Badano, J. L., Ansley, S. J., Leitch, C. C., Lewis, R. A., Lupski, J. R., Katsanis, N. (2003) Identification of a novel Bardet-Biedl syndrome protein, BBS7, that shares structural features with BBS1 and BBS2. Am J Hum Genet. 72: 650658.
  • 50
    Beales, P. L., Badano, J. L., Ross, A. J., et al (2003) Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome. Am J Hum Genet. 72: 11871199.
  • 51
    Mykytyn, K., Nishimura, D. Y., Searby, C. C., et al (2003) Evaluation of complex inheritance involving the most common Bardet-Biedl syndrome locus (BBS1). Am J Hum Genet. 72: 429437.
  • 52
    Agarwal, A. K., Simha, V., Oral, E. A., et al (2003) Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab. 88: 48404847.
  • 53
    Kolehmainen, J., Black, G. C., Saarinen, A., et al (2003) Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am J Hum Genet. 72: 13591369.
  • 54
    Odievre, M. H., Lombes, A., Dessemme, P., et al (2002) A secondary respiratory chain defect in a patient with Fanconi-Bickel syndrome. J Inherit Metab Dis. 25: 379384.
  • 55
    Matsuura, T., Tamura, T., Chinen, Y., Ohta, T. (2002) A novel mutation (N32K) of GLUT2 gene in a Japanese patient with Fanconi-Bickel syndrome. Clin Genet. 62: 255256.
  • 56
    Baumstark, A., Lower, K. M., Sinkus, A., et al (2003) Novel PHF6 mutation p. D333del causes Borjeson-Forssman-Lehmann syndrome. J Med Genet. 40: e50
  • 57
    Castro, N. H., dos Santos, R. C., Nelson, R., et al (2003) Shashi XLMR syndrome: report of a second family. Am J Med Genet. 118A: 4951.
  • 58
    Li, M., Shuman, C., Fei, Y. L., et al (2001) GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome. Am J Med Genet. 102: 161168.
  • 59
    Mariani, S., Iughetti, L., Bertorelli, R., et al (2003) Genotype/phenotype correlations of males affected by Simpson-Golabi-Behmel syndrome with GPC3 gene mutations: patient report and review of the literature. J Pediatr Endocrinol Metab. 16: 225232.
  • 60
    Fryns, J. P., Haspeslagh, M., Dereymaeker, A. M., Volcke, P., Van den Berghe, H. (1987) A peculiar subphenotype in the fra(X) syndrome: extreme obesity-short stature-stubby hands and feet-diffuse hyperpigmentation. Further evidence of disturbed hypothalamic function in the fra(X) syndrome? Clin Genet. 32: 388392.
  • 61
    de Vries, B. B., Fryns, J. P., Butler, M. G., et al (1993) Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype. J Med Genet. 30: 761766.
  • 62
    Schrander-Stumpel, C., Gerver, W. J., Meyer, H., Engelen, J., Mulder, H., Fryns, JP. (1994) Prader-Willi-like phenotype in fragile X syndrome. Clin Genet. 45: 175180.
  • 63
    Quan, F., Zonana, J., Gunter, K., Peterson, K. L., Magenis, R. E., Popovich, BW. (1995) An atypical case of fragile X syndrome caused by a deletion that includes the FMR1 gene. Am J Hum Genet. 56: 10421051.
  • 64
    Phan, L. K., Lin, F., LeDuc, C. A., Chung, W. K., Leibel, RL. (2002) The mouse mahoganoid coat color mutation disrupts a novel C3HC4 RING domain protein. J Clin Invest. 110: 14491459.
  • 65
    Miller, K. A., Gunn, T. M., Carrasquillo, M. M., Lamoreux, M. L., Galbraith, D. B., Barsh, GS. (1997) Genetic studies of the mouse mutations mahogany and mahoganoid. Genetics. 146: 14071415.
  • 66
    Kero, J. T., Savontaus, E., Mikola, M., et al (2003) Obesity in transgenic female mice with constitutively elevated luteinizing hormone secretion. Am J Physiol Endocrinol Metab. 285: E812E818.
  • 67
    Matsumoto, T., Takeyama, K., Sato, T., Kato, S. (2003) Androgen receptor functions from reverse genetic models. J Steroid Biochem Mol Biol. 85: 9599.
  • 68
    Bradshaw, A. D., Graves, D. C., Motamed, K., Sage, EH. (2003) SPARC-null mice exhibit increased adiposity without significant differences in overall body weight. Proc Natl Acad Sci U S A. 100: 60456050.
  • 69
    Wallenius, V., Wallenius, K., Ahren, B., et al (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat Med. 8: 7579.
  • 70
    Serra, C., Federici, M., Buongiorno, A., et al (2003) Transgenic mice with dominant negative PKC-theta in skeletal muscle: a new model of insulin resistance and obesity. J Cell Physiol. 196: 8997.
  • 71
    Hirosumi, J., Tuncman, G., Chang, L., et al (2002) A central role for JNK in obesity and insulin resistance. Nature. 420: 333336.
  • 72
    Walz, K., Caratini-Rivera, S., Bi, W., et al (2003) Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) contiguous gene syndromes by chromosome engineering in mice: phenotypic consequences of gene dosage imbalance. Mol Cell Biol. 23: 36463655.
  • 73
    Mouse Genome Database (MGD). (Accessed December 2003) Mouse Genome Informatics Web Site. The Jackson Laboratory Bar Harbor, ME. http:www.informatics.jax.org.
  • 74
    DeBry, R. W., Seldin, MF. (1996) Human/mouse homology relationships. Genomics. 33: 337351.
  • 75
    Yamada, J., Kuramoto, T., Serikawa, T. (1994) A rat genetic linkage map and comparative maps for mouse or human homologous rat genes. Mamm Genome. 5: 6383.
  • 76
    Jacob, H. J., Brown, D. M., Bunker, R. K., et al (1995) A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet. 9: 6369.
  • 77
    Animal Genome Database (AGP). (Accessed December, 2003) Animal Genome Research Program Tsukuba, Ibaraki, Japan http:animal.dna.affrc.go.jpagp.
  • 78
    National Animal Genome Research Program. (Accessed December, 2003) U.S. Livestock Genome Mapping Projects Ames, Iowa. http:www.genome.iastate.edu.
  • 79
    Smith Richards B. K., Belton, B. N., Poole, A. C., et al (2002) QTL analysis of self-selected macronutrient diet intake: fat, carbohydrate, and total kilocalories. Physiol Genomics. 11: 205217.
  • 80
    Zhang, S., Gershenfeld, HK. (2003) Genetic contributions to body weight in mice: relationship of exploratory behavior to weight. Obes Res. 11: 828838.
  • 81
    Reed, D. R., Li, X., McDaniel, A. H., et al (2003) Loci on chromosomes 2, 4, 9, and 16 for body weight, body length, and adiposity identified in a genome scan of an F2 intercross between the 129P3/J and C57BL/6ByJ mouse strains. Mamm Genome. 14: 302313.
  • 82
    Almind, K., Kulkarni, R. N., Lannon, S. M., Kahn, CR. (2003) Identification of interactive loci linked to insulin and leptin in mice with genetic insulin resistance. Diabetes. 52: 15351543.
  • 83
    Harper, J. M., Galecki, A. T., Burke, D. T., Pinkosky, S. L., Miller, RA. (2003) Quantitative trait loci for insulin-like growth factor I, leptin, thyroxine, and corticosterone in genetically heterogeneous mice. Physiol Genomics. 15: 4451.
  • 84
    Strazzullo, P., Iacone, R., Iacoviello, L., et al (2003) Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study. Ann Intern Med. 138: 1723.
  • 85
    Pereira, A. C., Floriano, M. S., Mota, G. F., et al (2003) Beta2 adrenoceptor functional gene variants, obesity, and blood pressure level interactions in the general population. Hypertension. 42: 685692.
  • 86
    Arashiro, R., Katsuren, K., Fukuyama, S., Ohta, T. (2003) Effect of Trp64Arg mutation of the beta3-adrenergic receptor gene and C161T substitution of the peroxisome proliferator activated receptor gamma gene on obesity in Japanese children. Pediatr Int. 45: 135141.
  • 87
    Argyropoulos, G., Rankinen, T., Bai, F., et al (2003) The agouti-related protein and body fatness in humans. Int J Obes Relat Metab Disord. 27: 276280.
  • 88
    Yang, W. S., Tsou, P. L., Lee, W. J., et al (2003) Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med. 81: 428434.
  • 89
    Ukkola, O., Ravussin, E., Jacobson, P., Sjöström, L., Bouchard, C. (2003) Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism. 52: 881884.
  • 90
    Ma, Y. Q., Thomas, G. N., Ng, M. C., et al (2003) Association of two apolipoprotein A-I gene MspI polymorphisms with high density lipoprotein (HDL)-cholesterol levels and indices of obesity in selected healthy Chinese subjects and in patients with early-onset type 2 diabetes. Clin Endocrinol (Oxf). 59: 442449.
  • 91
    Fiegenbaum, M., Hutz, MH. (2003) Further evidence for the association between obesity-related traits and the apolipoprotein A-IV gene. Int J Obes Relat Metab Disord. 27: 484490.
  • 92
    Ukkola, O., Joanisse, D. R., Tremblay, A., Bouchard, C. (2003) Na+-K+-ATPase alpha 2-gene and skeletal muscle characteristics in response to long-term overfeeding. J Appl Physiol. 94: 18701874.
  • 93
    Shima, Y., Nakanishi, K., Odawara, M., Kobayashi, T., Ohta, H. (2003) Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese. Clin Chim Acta. 336: 8996.
  • 94
    Okura, T., Koda, M., Ando, F., Niino, N., Ohta, S., Shimokata, H. (2003) Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int J Obes Relat Metab Disord. 27: 10201027.
  • 95
    Damcott, C. M., Feingold, E., Moffett, S. P., et al (2003) Variation in the FABP2 promoter alters transcriptional activity and is associated with body composition and plasma lipid levels. Hum Genet. 112: 610616.
  • 96
    Kovacs, P., Lehn-Stefan, A., Stumvoll, M., Bogardus, C., Baier, LJ. (2003) Genetic variation in the human winged helix/forkhead transcription factor gene FOXC2 in Pima Indians. Diabetes. 52: 12921295.
  • 97
    Brand, E., Wang, J. G., Herrmann, S. M., Staessen, JA. (2003) An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gbeta3 C825T polymorphism. J Hypertens. 21: 729737.
  • 98
    Gelernter-Yaniv, L., Feng, N., Sebring, N. G., Hochberg, Z., Yanovski, JA. (2003) Associations between a polymorphism in the 11 beta hydroxysteroid dehydrogenase type I gene and body composition. Int J Obes Relat Metab Disord. 27: 983986.
  • 99
    Berthier, M. T., Paradis, A. M., Tchernof, A., et al (2003) The interleukin 6–174G/C polymorphism is associated with indices of obesity in men. J Hum Genet. 48: 1419.
  • 100
    Escobar-Morreale, H. F., Calvo, R. M., Villuendas, G., Sancho, J., San Millan JL. (2003) Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism. Obes Res. 11: 987996.
  • 101
    Stefan, N., Kovacs, P., Stumvoll, M., et al (2003) Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity. Diabetes. 52: 15441550.
  • 102
    St-Pierre, J., Miller-Felix, I., Paradis, M. E., et al (2003) Visceral obesity attenuates the effect of the hepatic lipase −514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men. Mol Genet Metab. 78: 3136.
  • 103
    Iliadou, A., Lichtenstein, P., Ahlberg, S., et al (2003) No linkage to obesity in candidate regions of chromosome 2 and 10 in a selected sample of Swedish twins. Twin Res. 6: 162169.
  • 104
    Iwai, N., Mannami, T., Tomoike, H., Ono, K., Iwanaga, Y. (2003) An acyl-CoA synthetase gene family in chromosome 16p12 may contribute to multiple risk factors. Hypertension. 41: 10411046.
  • 105
    Wasserman, L., Flatt, S. W., Natarajan, L., et al (2004) Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors. Int J Obes Relat Metab Disord. 28: 4956.
  • 106
    Hung, C. C., Farooqi, I. S., Ong, K., et al (2003) Contribution of variants in the small heterodimer partner gene to birthweight, adiposity, and insulin levels: mutational analysis and association studies in multiple populations. Diabetes. 52: 12881291.
  • 107
    Di Blasio, A. M., van Rossum, E. F., Maestrini, S., et al (2003) The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients. Clin Endocrinol (Oxf). 59: 6874.
  • 108
    Roussel, R., Reis, A. F., Dubois-Laforgue, D., Bellanne-Chantelot, C., Timsit, J., Velho, G. (2003) The N363S polymorphism in the glucocorticoid receptor gene is associated with overweight in subjects with type 2 diabetes mellitus. Clin Endocrinol (Oxf). 59: 237241.
  • 109
    Bosse, Y., Despres, J. P., Bouchard, C., Perusse, L., Vohl, MC. (2003) The peroxisome proliferator-activated receptor alpha L162V mutation is associated with reduced adiposity. Obes Res. 11: 809816.
  • 110
    Rosmond, R., Chagnon, M., Bouchard, C. (2003) The Pro12Ala PPARgamma2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle-aged men. Diabetes Metab Res Rev. 19: 159163.
  • 111
    Doney, A., Fischer, B., Frew, D., et al (2002) Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet. 3: 21
  • 112
    Koumanis, D. J., Christou, N. V., Wang, X. L., Gilfix, BM. (2002) Pilot study examining the frequency of several gene polymorphisms in a morbidly obese population. Obes Surg. 12: 759764.
  • 113
    Robitaille, J., Despres, J. P., Perusse, L., Vohl, MC. (2003) The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study. Clin Genet. 63: 109116.
  • 114
    Kao, W. H., Coresh, J., Shuldiner, A. R., Boerwinkle, E., Bray, M. S., Brancati, FL. (2003) Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study. Diabetes. 52: 15681572.
  • 115
    Epstein, L. H., Jaroni, J. L., Paluch, R. A., et al (2002) Dopamine transporter genotype as a risk factor for obesity in African-American smokers. Obes Res. 10: 12321240.
  • 116
    Tonooka, N., Tomura, H., Takahashi, Y., et al (2002) High frequency of mutations in the HNF-1alpha gene in non-obese patients with diabetes of youth in Japanese and identification of a case of digenic inheritance. Diabetologia. 45: 17091712.
  • 117
    Rosmond, R., Chagnon, M., Bouchard, C., Björntorp, P. (2003) Increased abdominal obesity, insulin and glucose levels in nondiabetic subjects with a T29C polymorphism of the transforming growth factor-beta1 gene. Horm Res. 59: 191194.
  • 118
    Zitzmann, M., Gromoll, J., von Eckardstein, A., Nieschlag, E. (2003) The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia. 46: 3139.
  • 119
    Roth, S. M., Metter, E. J., Lee, M. R., Hurley, B. F., Ferrell, RE. (2003) C174T polymorphism in the CNTF receptor gene is associated with fat-free mass in men and women. J Appl Physiol. 95: 14251430.
  • 120
    Corbalan, M. S., Marti, A., Forga, L., Martinez-Gonzalez, M. A., Martinez, JA. (2002) Beta(2)-adrenergic receptor mutation and abdominal obesity risk: effect modification by gender and HDL-cholesterol. Eur J Nutr. 41: 114118.
  • 121
    Gonzalez-Sanchez, J. L., Proenza, A. M., Martinez Larrad M. T., et al (2003) The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain. Clin Endocrinol (Oxf). 59: 476481.
  • 122
    Gustafson, D. R., Wen, M. J., Koppanati, BM. (2003) Androgen receptor gene repeats and indices of obesity in older adults. Int J Obes Relat Metab Disord. 27: 7581.
  • 123
    Baghaei, F., Rosmond, R., Westberg, L., et al (2003) The CYP19 gene and associations with androgens and abdominal obesity in premenopausal women. Obes Res. 11: 578585.
  • 124
    Ukkola, O., Chagnon, M., Tremblay, A., Bouchard, C. (2003) Genetic variation at the adipsin locus and response to long-term overfeeding. Eur J Clin Nutr. 57: 10731078.
  • 125
    Herrmann, S. M., Wang, J. G., Staessen, J. A., et al (2003) Uncoupling protein 1 and 3 polymorphisms are associated with waist-to-hip ratio. J Mol Med. 81: 327332.
  • 126
    Walston, J., Andersen, R. E., Seibert, M., et al (2003) Arg64 beta3-adrenoceptor variant and the components of energy expenditure. Obes Res. 11: 509511.
  • 127
    Kubaszek, A., Pihlajamaki, J., Punnonen, K., Karhapaa, P., Vauhkonen, I., Laakso, M. (2003) The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes. 52: 558561.
  • 128
    Stefan, N., Vozarova, B., Del Parigi, A., et al (2002) The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism. Int J Obes Relat Metab Disord. 26: 16291632.
  • 129
    Muller, Y. L., Bogardus, C., Beamer, B. A., Shuldiner, A. R., Baier, LJ. (2003) A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians. Diabetes. 52: 18641871.
  • 130
    Muller, Y. L., Bogardus, C., Pedersen, O., Baier, L. (2003) A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. Diabetes. 52: 895898.
  • 131
    Mottagui-Tabar, S., Ryden, M., Lofgren, P., et al (2003) Evidence for an important role of perilipin in the regulation of human adipocyte lipolysis. Diabetologia. 46: 789797.
  • 132
    Gonzalez-Sanchez, J. L., Martinez-Larrad, M. T., Fernandez-Perez, C., Kubaszek, A., Laakso, M., Serrano-Rios, M. (2003) K121Q PC-1 gene polymorphism is not associated with insulin resistance in a Spanish population. Obes Res. 11: 603605.
  • 133
    Schalin-Jantti, C., Valli-Jaakola, K., Oksanen, L., et al (2003) Melanocortin-3-receptor gene variants in morbid obesity. Int J Obes Relat Metab Disord. 27: 7074.
  • 134
    Suviolahti, E., Ridderstrale, M., Almgren, P., et al (2003) Pro-opiomelanocortin gene is associated with serum leptin levels in lean but not in obese individuals. Int J Obes Relat Metab Disord. 27: 12041211.
  • 135
    Matsushita, H., Kurabayashi, T., Tomita, M., Kato, N., Tanaka, K. (2003) Effects of uncoupling protein 1 and beta3-adrenergic receptor gene polymorphisms on body size and serum lipid concentrations in Japanese women. Maturitas. 45: 3945.
  • 136
    Tremblay, A., Bouchard, L., Bouchard, C., Despres, J. P., Drapeau, V., Perusse, L. (2003) Long-term adiposity changes are related to a glucocorticoid receptor polymorphism in young females. J Clin Endocrinol Metab. 88: 31413145.
  • 137
    Dishy, V., Gupta, S., Landau, R., et al (2003) G-protein beta3 subunit 825 C/T polymorphism is associated with weight gain during pregnancy. Pharmacogenetics. 13: 241242.
  • 138
    Hauner, H., Meier, M., Jockel, K. H., Frey, U. H., Siffert, W. (2003) Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism. Pharmacogenetics. 13: 453459.
  • 139
    Peters, W. R., MacMurry, J. P., Walker, J., Giese, R. J. Jr, Comings, DE. (2003) Phenylethanolamine N-methyltransferase G-148A genetic variant and weight loss in obese women. Obes Res. 11: 415419.
  • 140
    Shiwaku, K., Nogi, A., Anuurad, E., et al (2003) Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene. Int J Obes Relat Metab Disord. 27: 10281036.
  • 141
    Garenc, C., Perusse, L., Chagnon, Y. C., et al (2003) Effects of beta2-adrenergic receptor gene variants on adiposity: the HERITAGE Family Study. Obes Res. 11: 612618.
  • 142
    Schauble, N., Geller, F., Siegfried, W., et al (2003) No evidence for involvement of the promoter polymorphism −866 G/A of the UCP2 gene in childhood-onset obesity in humans. Exp Clin Endocrinol Diabetes. 111: 7376.
  • 143
    Duarte, N. L., Colagiuri, S., Palu, T., Wang, X. L., Wilcken, DE. (2003) A 45-bp insertion/deletion polymorphism of uncoupling protein 2 in relation to obesity in Tongans. Obes Res. 11: 512517.
  • 144
    Sesti, G., Cardellini, M., Marini, M. A., et al (2003) A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes. 52: 12801283.
  • 145
    Rosmond, R., Bouchard, C., Björntorp, P. (2002) Lack of association between the uncoupling protein-2 Ala55Val gene polymorphism and phenotypic features of the Metabolic Syndrome. Biochim Biophys Acta. 1588: 103105.
  • 146
    Sivenius, K., Niskanen, L., Laakso, M., Uusitupa, M. (2003) A deletion in the alpha2B-adrenergic receptor gene and autonomic nervous function in central obesity. Obes Res. 11: 962970.
  • 147
    Suzuki, N., Matsunaga, T., Nagasumi, K., et al (2003) Alpha(2B)-adrenergic receptor deletion polymorphism associates with autonomic nervous system activity in young healthy Japanese. J Clin Endocrinol Metab. 88: 11841187.
  • 148
    Sykiotis, G. P., Polyzogopoulou, E., Georgopoulos, N. A., et al (2003) The alpha2B adrenergic receptor deletion/insertion polymorphism in morbid obesity. Clin Auton Res. 13: 203207.
  • 149
    Martinez, J. A., Corbalan, M. S., Sanchez-Villegas, A., Forga, L., Marti, A., Martinez-Gonzalez, MA. (2003) Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism. J Nutr. 133: 25492554.
  • 150
    van Tilburg, J. H., Wijmenga, C., van Bakel, H., Rozeman, L., Pearson, P. L., van Haeften, TW. (2003) Relationship of beta2-adrenergic receptor polymorphism with obesity in type 2 diabetes. Diabetes Care. 26: 251252.
  • 151
    Duarte, N. L., Colagiuri, S., Palu, T., Wang, X. L., Wilcken, DE. (2003) Obesity, type II diabetes and the beta 2 adrenoceptor gene Gln27Glu polymorphism in the Tongan population. Clin Sci (Lond). 104: 211215.
  • 152
    Ahluwalia, M., Evans, M., Morris, K., et al (2002) The influence of the Pro12Ala mutation of the PPAR-gamma receptor gene on metabolic and clinical characteristics in treatment-naive patients with type 2 diabetes. Diabetes Obes Metab. 4: 376378.
  • 153
    Bluher, M., Paschke, R. (2003) Analysis of the Relationship between PPAR-gamma 2 gene variants and severe insulin resistance in obese patients with impaired glucose tolerance. Exp Clin Endocrinol Diabetes. 111: 8590.
  • 154
    Urbanek, M., Du, Y., Silander, K., et al (2003) Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes. 52: 214217.
  • 155
    Ochi, M., Osawa, H., Onuma, H., et al (2003) The absence of evidence for major effects of the frequent SNP +299G>A in the resistin gene on susceptibility to insulin resistance syndrome associated with Japanese type 2 diabetes. Diabetes Res Clin Pract. 61: 191198.
  • 156
    Smith, S. R., Bai, F., Charbonneau, C., Janderova, L., Argyropoulos, G. (2003) A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes. 52: 16111618.
  • 157
    Um, J. Y., Mun, K. S., An, N. H., et al (2003) Polymorphism of angiotensin-converting enzyme gene and BMI in obese Korean women. Clin Chim Acta. 328: 173178.
  • 158
    Okumura, K., Matsui, H., Ogawa, Y., et al (2003) The polymorphism of the beta3-adrenergic receptor gene is associated with reduced low-density lipoprotein particle size. Metabolism. 52: 356361.
  • 159
    Marques-Vidal, P., Bongard, V., Ruidavets, J. B., et al (2003) Obesity and alcohol modulate the effect of apolipoprotein E polymorphism on lipids and insulin. Obes Res. 11: 12001206.
  • 160
    Guerra, A., Rego, C., Castro, E. M., Seixas, S., Rocha, J. (2003) Influence of apolipoprotein e polymorphism on cardiovascular risk factors in obese children. Ann Nutr Metab. 47: 4954.
  • 161
    Rasmussen, S. K., Urhammer, S. A., Berglund, L., et al (2002) Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes. 51: 35613567.
  • 162
    Malecki, M. T., Klupa, T., Wolkow, P., Bochenski, J., Wanic, K., Sieradzki, J. (2003) Association study of the vitamin D: 1alpha-hydroxylase (CYP1alpha) gene and type 2 diabetes mellitus in a Polish population. Diabetes Metab. 29: 119124.
  • 163
    Coudreau, S. K., Tounian, P., Bonhomme, G., et al (2003) Role of the DGAT gene C79T single-nucleotide polymorphism in French obese subjects. Obes Res. 11: 11631167.
  • 164
    Southon, A., Walder, K., Sanigorski, A. M., et al (2003) The Taq IA and Ser311 Cys polymorphisms in the dopamine D2 receptor gene and obesity. Diabetes Nutr Metab. 16: 7276.
  • 165
    Treiber, F. A., Barbeau, P., Harshfield, G., et al (2003) Endothelin-1 gene Lys198Asn polymorphism and blood pressure reactivity. Hypertension. 42: 494499.
  • 166
    Jin, J. J., Nakura, J., Wu, Z., et al (2003) Association of endothelin-1 gene variant with hypertension. Hypertension. 41: 163167.
  • 167
    Milewicz, A., Demissie, M., Zatonska, K., et al (2003) Influence of dietary and genetic factors on metabolic status in obese and lean postmenopausal women. Gynecol Endocrinol. 17: 333338.
  • 168
    Berthier, M. T., Houde, A., Bergeron, J., PruD'homme, D., Despres, J. P., Vohl, MC. (2003) Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity. J Hum Genet. 48: 367373.
  • 169
    Duarte, N. L., Colagiuri, S., Palu, T., Wang, X. L., Wilcken, DE. (2003) Obesity, type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population. Mol Genet Metab. 79: 183188.
  • 170
    Masuda, K., Osada, H., Iitsuka, Y., Seki, K., Sekiya, S. (2002) Positive association of maternal G protein beta3 subunit 825T allele with reduced head circumference at birth. Pediatr Res. 52: 687691.
  • 171
    Bhattacharyya, S., Luan, J., Challis, B., et al (2003) Association of polymorphisms in GPR10, the gene encoding the prolactin-releasing peptide receptor with blood pressure, but not obesity, in a U.K. Caucasian population. Diabetes. 52: 12961299.
  • 172
    Huang, Q. Y., Shen, H., Deng, H. Y., et al (2003) Linkage and association of the CA repeat polymorphism of the IL6 gene, obesity-related phenotypes, and bone mineral density (BMD) in two independent Caucasian populations. J Hum Genet. 48: 430437.
  • 173
    Ortlepp, J. R., Metrikat, J., Vesper, K., et al (2003) The interleukin-6 promoter polymorphism is associated with elevated leukocyte, lymphocyte, and monocyte counts and reduced physical fitness in young healthy smokers. J Mol Med. 81: 578584.
  • 174
    Le Fur, S., Le Stunff, C., Bougneres, P. (2002) Increased insulin resistance in obese children who have both 972 IRS-1 and 1057 IRS-2 polymorphisms. Diabetes. 51: S304S307.
  • 175
    van Rossum, C. T., Hoebee, B., van Baak, M. A., Mars, M., Saris, W. H., Seidell, JC. (2003) Genetic variation in the leptin receptor gene, leptin, and weight gain in young Dutch adults. Obes Res. 11: 377386.
  • 176
    Ma, Y. Q., Thomas, G. N., Ng, M. C., Critchley, J. A., Chan, J. C., Tomlinson, B. (2003) The lipoprotein lipase gene HindIII polymorphism is associated with lipid levels in early-onset type 2 diabetic patients. Metabolism. 52: 338343.
  • 177
    Monti, L. D., Barlassina, C., Citterio, L., et al (2003) Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes. 52: 12701275.
  • 178
    Mitchell, S. M., Weedon, M. N., Owen, K. R., et al (2003) Genetic variation in the small heterodimer partner gene and young-onset type 2 diabetes, obesity, and birth weight in U.K. subjects. Diabetes. 52: 12761279.
  • 179
    Witchel, S. F., Trivedi, R. N., Kammerer, C. (2003) Frequency of the T228A polymorphism in the SORBS1 gene in children with premature pubarche and in adolescent girls with hyperandrogenism. Fertil Steril. 80: 128132.
  • 180
    Pihlajamaki, J., Ylinen, M., Karhapaa, P., Vauhkonen, I., Laakso, M. (2003) The effect of the −308A allele of the TNF-alpha gene on insulin action is dependent on obesity. Obes Res. 11: 912917.
  • 181
    Adeyemo, A., Luke, A., Cooper, R., et al (2003) A genome-wide scan for body mass index among Nigerian families. Obes Res. 11: 266273.
  • 182
    Gorlova, O., Amos, C., Wang, N., Shete, S., Turner, S., Boerwinkle, E. (2003) Genetic linkage and imprinting effects on body mass index in children and young adults. Eur J Hum Genet. 11: 425432.
  • 183
    Palmer, L., Buxbaum, S., Larkin, E., et al (2003) A whole-genome scan for obstructive sleep apnea and obesity. Am J Hum Genet. 72: 340350.
  • 184
    Platte, P., Papanicolaou, G., Johnston, J., et al (2003) A study of linkage and association of body mass index in the Old Order Amish. Am J Med Genet. 121C: 7180.
  • 185
    Luke, A., Wu, X., Zhu, X., Kan, D., Su, Y., Cooper, R. (2003) Linkage for BMI at 3q27 region confirmed in an African-American population. Diabetes. 52: 12841287.
  • 186
    Li, W. D., Li, D., Wang, S., Zhang, S., Zhao, H., Price, RA. (2003) Linkage and linkage disequilibrium mapping of genes influencing human obesity in chromosome region 7q22.1–7q35. Diabetes. 52: 15571561.
  • 187
    Dong, C., Wang, S., Li, W., Li, D., Zhao, H., Price, R. (2003) Interacting genetic loci on chromosomes 20 and 10 influence extreme human obesity. Am J Hum Genet. 72: 115124.
  • 188
    Saar, K., Geller, F., Ruschendorf, F., et al (2003) Genome scan for childhood and adolescent obesity in German families. Pediatrics. 111: 321327.
  • 189
    Comuzzie, A. G., Hixson, J. E., Almasy, L., et al (1997) A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet. 15: 273276.
  • 190
    Hager, J., Dina, C., Francke, S., et al (1998) A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet. 20: 304308.
  • 191
    Kissebah, A., Sonnenberg, G., Myklebust, J., et al (2000) Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci U S A. 97: 1447814483.
  • 192
    Clement, K., Vaisse, C., Lahlou, N., et al (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 392: 398401.
  • 193
    Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., Gruters, A. (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 19: 155157.
  • 194
    Jackson, R. S., Creemers, J. W. M., Ohagi, S., et al (1997) Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet. 16: 303306.
  • 195
    Montague, C. T., Farooqi, I. S., Whitehead, J. P., et al (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 387: 903908.
  • 196
    Ozata, M., Ozdemir, I. C., Licinio, J. (1999) Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab. 84: 36863685.
  • 197
    Strobel, A., Issad, T., Camoin, L., Ozata, M., Strosberg, AD. (1998) A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet. 18: 213215.
  • 198
    Dubern, B., Clement, K., Pelloux, V., et al (2001) Mutational analysis of melanocortin-4 receptor, agouti-related protein, and alpha-melanocyte-stimulating hormone genes in severely obese children. J Pediatr. 139: 204209.
  • 199
    Farooqi, I. S., Yeo, G. S., Keogh, J. M., et al (2000) Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest. 106: 271279.
  • 200
    Hamann, A., Busing, B., Munzberg, H., et al (1999) Missense variants in the human cholecystokinin type A receptor gene: no evidence for association with early-onset obesity. Horm Metab Res. 31: 287288.
  • 201
    Gu, W., Tu, Z., Kleyn, P. W., et al (1999) Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes. 48: 635639.
  • 202
    Hinney, A., Schmidt, A., Nottebom, K., et al (1999) Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab. 84: 14831486.
  • 203
    Sina, M., Hinney, A., Ziegler, A., et al (1999) Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. Am J Hum Genet. 65: 15011507.
  • 204
    Jacobson, P., Ukkola, O., Rankinen, T., et al (2002) Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish Obese Subjects, the HERITAGE Family Study, and a Memphis cohort. J Clin Endocrinol Metab. 87: 44424446.
  • 205
    Kobayashi, H., Ogawa, Y., Shintani, M., et al (2002) A novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity. Diabetes. 51: 243246.
  • 206
    Lubrano-Berthelier, C., Durand, E., Dubern, B., et al (2003) Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum Mol Genet. 12: 145153.
  • 207
    Vaisse, C., Clement, K., Durand, E., Hercberg, S., Guy-Grand, B., Froguel, P. (2000) Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest. 106: 253262.
  • 208
    Vaisse, C., Clement, K., Guy-Grand, B., Froguel, P. (1998) A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet. 20: 113114.
  • 209
    Yeo, G. S. H., Farooqi, I. S., Aminian, S., Halsall, D. J., Stanhope, RG. (1998) A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet. 20: 111112.
  • 210
    Collin, G. B., Marshall, J. D., Boerkoel, C. F., et al (1999) Alstrom syndrome: further evidence for linkage to human chromosome 2p13. Hum Genet. 105: 474479.
  • 211
    Collin, G. B., Marshall, J. D., Ikeda, A., et al (2002) Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nat Genet. 31: 7478.
  • 212
    Hearn, T., Renforth, G. L., Spalluto, C., et al (2002) Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstrom syndrome. Nat Genet. 31: 7983.
  • 213
    Macari, F., Lautier, C., Girardet, A., et al (1998) Refinement of genetic localization of the Alstrom syndrome on chromosome 2p12–13 by linkage analysis in a North African family. Hum Genet. 103: 658661.
  • 214
    Katsanis, N., Lewis, R. A., Stockton, D. W., et al (1999) Delineation of the critical interval of Bardet-Biedl syndrome 1 (BBS1) to a small region of 11q13, through linkage and haplotype analysis of 91 pedigrees. Am J Hum Genet. 65: 16721679.
  • 215
    Mykytyn, K., Nishimura, D. Y., Searby, C. C., et al (2002) Identification of the gene (BBS1) most commonly involved in Bardet- Biedl syndrome, a complex human obesity syndrome. Nat Genet. 31: 435438.
  • 216
    Young, T. L., Woods, M. O., Parfrey, P. S., Green, J. S., Hefferton, D., Davidson, WS. (1999) A founder effect in the newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cM. Am J Hum Genet. 65: 16801687.
  • 217
    Bruford, E. A., Riise, R., Teague, P. W., et al (1997) Linkage mapping in 29 Bardet-Biedl syndrome families confirms loci in chromosomal regions 11q13, 15q22.3-q23, and 16q21. Genomics. 41: 9399.
  • 218
    Kwitek-Black, A. E., Carmi, R., Duyk, G. M., et al (1993) Linkage of Bardet-Biedl syndrome to chromosome 16q and evidence for non-allelic genetic heterogeneity. Nat Genet. 5: 392396.
  • 219
    Nishimura, D. Y., Searby, C. C., Carmi, R., et al (2001) Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet. 10: 865874.
  • 220
    Beales, P. L., Katsanis, N., Lewis, R. A., et al (2001) Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort reveal a minor involvement of BBS6 and delineate the critical intervals of other loci. Am J Hum Genet. 68: 606616.
  • 221
    Sheffield, V. C., Carmi, R., Kwitek-Black, A., et al (1994) Identification of a Bardet-Biedl syndrome locus on chromosome 3 and evaluation of an efficient approach to homozygosity mapping. Hum Mol Genet. 3: 13311335.
  • 222
    Young, T. L., Woods, M. O., Parfrey, P. S., et al (1998) Canadian Bardet-Biedl syndrome family reduces the critical region of BBS3 (3p) and presents with a variable phenotype. Am J Med Genet. 78: 461467.
  • 223
    Carmi, R., Rokhlina, T., Kwitek-Black, A. E., et al (1995) Use of a DNA pooling strategy to identify a human obesity syndrome locus on chromosome 15. Hum Mol Genet. 4: 913.
  • 224
    Gorman, S., Haider, N., Grieshammer, U., et al (1999) The cloning and developmental expression of unconventional myosin IXA (MYO9A) a gene in the Bardet-Biedl syndrome (BBS4) region at chromosome 15q22–q23. Genomics. 59: 150160.
  • 225
    Katsanis, N., Eichers, E. R., Ansley, S. J., et al (2002) BBS4 is a minor contributor to Bardet-Biedl syndrome and may also participate in triallelic inheritance. Am J Hum Genet. 71: 2229.
  • 226
    Mykytyn, K., Braun, T., Carmi, R., et al (2001) Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat Genet. 28: 188191.
  • 227
    Woods, M., Young, T., Parfrey, P., Hefferton, D., Green, J., Davidson, W. (1999) Genetic heterogeneity of Bardet-Biedl syndrome in a distinct Canadian population: evidence for a fifth locus. Genomics. 55: 29.
  • 228
    Young, T. L., Penney, L., Woods, M. O., et al (1999) A fifth locus for Bardet-Biedl syndrome maps to chromosome 2q31. Am J Hum Genet. 64: 900904.
  • 229
    Katsanis, N., Beales, P. L., Woods, M. O., et al (2000) Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with bardet-biedl syndrome. Nat Genet. 26: 6770.
  • 230
    Slavotinek, A. M., Stone, E. M., Mykytyn, K., et al (2000) Mutations in MKKS cause Bardet-Biedl syndrome. Nat Genet. 26: 1516.
  • 231
    Slavotinek, A. M., Searby, C., Al-Gazali, L., et al (2002) Mutation analysis of the MKKS gene in McKusick-Kaufman syndrome and selected Bardet-Biedl syndrome patients. Hum Genet. 110: 561567.
  • 232
    Agarwal, A. K., Arioglu, E., De Almeida, S., et al (2002) AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet. 31: 2123.
  • 233
    Garg, A., Wilson, R., Barnes, R., et al (1999) A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J Clin Endocrinol Metab. 84: 33903394.
  • 234
    Magre, J., Delepine, M., Khallouf, E., et al (2001) Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet. 28: 365370.
  • 235
    Heathcote, K., Rajab, A., Magre, J., et al (2002) Molecular analysis of Berardinelli-Seip congenital lipodystrophy in Oman: evidence for multiple loci. Diabetes. 51: 12911293.
  • 236
    Rajab, A., Heathcote, K., Joshi, S., Jeffery, S., Patton, M. (2002) Heterogeneity for congenital generalized lipodystrophy in seventeen patients from Oman. Am J Med Genet. 110: 219225.
  • 237
    Matthijs, G., Schollen, E., Pardon, E., et al (1997) Mutations in PMMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet. 16: 8892. [Published erratum in Nat Genet. 1997;16:316].
  • 238
    Kivitie-Kallio, S., Norio, R. (2001) Cohen syndrome: essential features, natural history, and heterogeneity. Am J Med Genet. 102: 125135.
  • 239
    Tahvanainen, E., Norio, R., Karila, E., et al (1994) Cohen syndrome gene assigned to the long arm of chromosome 8 by linkage analysis. Nat Genet. 7: 201204.
  • 240
    Mendonca, B. B., Osorio, M. G., Latronico, A. C., Estefan, V., Lo, L. S., Arnhold, IJ. (1999) Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301, G302 in the PROP1 gene. J Clin Endocrinol Metab. 84: 942945.
  • 241
    Rosenbloom, A. L., Almonte, A. S., Brown, M. R., Fisher, D. A., Baumbach, L., Parks, JS. (1999) Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab. 84: 5057.
  • 242
    Akagi, M., Inui, K., Nakajima, S., et al (2000) Mutation analysis of two Japanese patients with Fanconi-Bickel syndrome. J Hum Genet. 45: 6062.
  • 243
    Burwinkel, B., Sanjad, S. A., Al-Sabban, E., Al-Abbad, A., Kilimann, MW. (1999) A mutation in GLUT2, not in phosphorylase kinase subunits, in hepato-renal glycogenosis with Fanconi syndrome and low phosphorylase kinase activity. Hum Genet. 105: 240243.
  • 244
    Santer, R., Schneppenheim, R., Dombrowski, A., Gotze, H., Steinmann, B., Schaub, J. (1997) Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat Genet. 17: 324326. [Published erratum in Nat Genet. 1998;18:298].
  • 245
    Santer, R., Groth, S., Kinner, M., et al (2002) The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome. Hum Genet. 110: 2129.
  • 246
    Sakamoto, O., Ogawa, E., Ohura, T., et al (2000) Mutation analysis of the GLUT2 gene in patients with Fanconi-Bickel syndrome. Pediatr Res. 48: 586589.
  • 247
    Tsuda, M., Kitasawa, E., Ida, H., Eto, Y., Owada, M. (2000) A newly recognized missense mutation in the GLUT2 gene in a patient with Fanconi-Bickel syndrome. Eur J Pediatr. 159: 867
  • 248
    Salvatori, R., Hayashida, C. Y., Aguiar-Oliveira, M. H., et al (1999) Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J Clin Endocrinol Metab. 84: 917923.
  • 249
    Wajnrajch, M. P., Gertner, J. M., Harbison, M. D., Chua, S. C., Leibel, RL. (1996) Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet. 12: 8890.
  • 250
    Bellus, G. A., Hefferon, T. W., de Luna, R. I. Ortiz, et al (1995) Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet. 56: 368373.
  • 251
    Rousseau, F., Bonaventure, J., Legeai-Mallet, L., et al (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 371: 252254.
  • 252
    Shiang, R., Thompson, L. M., Zhu, Y. Z., et al (1994) Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 78: 335342.
  • 253
    Superti-Furga, A., Eich, G., Bucher, H. U., et al (1995) A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur J Pediatr. 154: 215219.
  • 254
    Ahmed, S. F., Dixon, P. H., Bonthron, D. T., et al (1998) GNAS1 mutational analysis in pseudohypoparathyroidism. Clin Endocrinol (Oxf). 49: 525531.
  • 255
    Aldred, M. A., Trembath, RC. (2000) Activating and inactivating mutations in the human GNAS1 gene. Hum Mutat. 16: 183189.
  • 256
    Farfel, Z., Iiri, T., Shapira, H., Roitman, A., Mouallem, M., Bourne, HR. (1996) Pseudohypoparathyroidism, a novel mutation in the beta gamma-contact region of Gs alpha impairs receptor stimulation. J Biol Chem. 271: 1965319655.
  • 257
    Fischer, J. A., Egert, F., Werder, E., Born, W. (1998) An inherited mutation associated with functional deficiency of the alpha-subunit of the guanine nucleotide-binding protein Gs in pseudo- and pseudopseudohypoparathyroidism. J Clin Endocrinol Metab. 83: 935938.
  • 258
    Iiri, T., Herzmark, P., Nakamoto, J. M., van Dop, C., Bourne, HR. (1994) Rapid GDP release from Gs alpha in patients with gain and loss of endocrine function. Nature. 371: 164168.
  • 259
    Ishikawa, Y., Tajima, T., Nakae, J., et al (2001) Two mutations of the Gsalpha gene in two Japanese patients with sporadic pseudohypoparathyroidism type Ia. J Hum Genet. 46: 426430.
  • 260
    Patten, J. L., Johns, D. R., Valle, D., et al (1990) Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med. 322: 14121419.
  • 261
    Schwindinger, W. F., Miric, A., Zimmerman, D., Levine, MA. (1994) A novel Gs alpha mutant in a patient with Albright hereditary osteodystrophy uncouples cell surface receptors from adenylyl cyclase. J Biol Chem. 269: 2538725391.
  • 262
    Warner, D. R., Gejman, P. V., Collins, R. M., Weinstein, LS. (1997) A novel mutation adjacent to the switch III domain of G(S alpha) in a patient with pseudohypoparathyroidism. Mol Endocrinol. 11: 17181727.
  • 263
    Warner, D. R., Weng, G., Yu, S., Matalon, R., Weinstein, LS. (1998) A novel mutation in the switch 3 region of Gsalpha in a patient with Albright hereditary osteodystrophy impairs GDP binding and receptor activation. J Biol Chem. 273: 2397623983.
  • 264
    Weinstein, L. S., Gejman, P. V., Friedman, E., et al (1990) Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci U S A. 87: 82878290.
  • 265
    Weinstein, L. S., Gejman, P. V., de Mazancourt, P., American, N., Spiegel, AM. (1992) A heterozygous 4-bp deletion mutation in the Gs alpha gene (GNAS1) in a patient with Albright hereditary osteodystrophy. Genomics. 13: 13191321.
  • 266
    Wilson, L. C., Oude Luttikhuis M. E., Clayton, P. T., Fraser, W. D., Trembath, RC. (1994) Parental origin of Gs alpha gene mutations in Albright's hereditary osteodystrophy. J Med Genet. 31: 835839.
  • 267
    Yu, D., Yu, S., Schuster, V., Kruse, K., Clericuzio, C., Weinstein, L. (1999) Identification of two novel deletion mutations within the G(s)alpha gene (GNAS1) in albright hereditary osteodystrophy. J Clin Endocrinol Metab. 84: 32543259.
  • 268
    Hedeland, H., Berntorp, K., Arheden, K., Kristoffersson, U. (1992) Pseudohypoparathyroidism type I and Albright's hereditary osteodystrophy with a proximal 15q chromosomal deletion in mother and daughter. Clin Genet. 42: 129134.
  • 269
    Gillessen-Kaesbach, G., Demuth, S., Thiele, H., Theile, U., Lich, C., Horsthemke, B. (1999) A previously unrecognised phenotype characterised by obesity, muscular hypotonia, and ability to speak in patients with Angelman syndrome caused by an imprinting defect. Eur J Hum Genet. 7: 638644.
  • 270
    Stratakis, C. A., Lafferty, A., Taymans, S. E., Gafni, R. I., Meck, J. M., Blancato, J. (2000) Anisomastia associated with interstitial duplication of chromosome 16, mental retardation, obesity, dysmorphic facies, and digital anomalies: molecular mapping of a new syndrome by fluorescent in situ hybridization and microsatellites to 16q13 (D16S419–D16S503). J Clin Endocrinol Metab. 85: 33963401.
  • 271
    Anderson, J., Khan, M., David, W., et al (1999) Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21–22. Am J Med Genet. 82: 161165.
  • 272
    Cao, H., Hegele, RA. (2000) Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 9: 109112.
  • 273
    Garg, A., Vinaitheerthan, M., Weatherall, P. T., Bowcock, AM. (2001) Phenotypic heterogeneity in patients with familial partial lipodystrophy (dunnigan variety) related to the site of missense mutations in lamin a/c gene. J Clin Endocrinol Metab. 86: 5965.
  • 274
    Peters, J., Barnes, R., Bennett, L., Gitomer, W., Bowcock, A., Garg, A. (1998) Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21–22. Nat Genet. 18: 292295.
  • 275
    Shackleton, S., Lloyd, D. J., Jackson, S. N., et al (2000) LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet. 24: 153156.
  • 276
    Speckman, R. A., Garg, A., Du, F., et al (2000) Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet. 66: 11921198.
  • 277
    Agarwal, A. K., Garg, A. (2002) A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J Clin Endocrinol Metab. 87: 408411.
  • 278
    Cama, A., de la Luz Sierra, M., Ottini, L., et al (1991) A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman. J Clin Endocrinol Metab. 73: 894901.
  • 279
    Globerman, H., Karnieli, E. (1998) Analysis of the insulin receptor gene tyrosine kinase domain in obese patients with hyperandrogenism, insulin resistance and acanthosis nigricans (type C insulin resistance). Int J Obes Relat Metab Disord. 22: 349353.
  • 280
    Kim, H., Kadowaki, H., Sakura, H., et al (1992) Detection of mutations in the insulin receptor gene in patients with insulin resistance by analysis of single-stranded conformational polymorphisms. Diabetologia. 35: 261266.
  • 281
    Krook, A., Kumar, S., Laing, I., Boulton, A. J., Wass, J. A., O'Rahilly, S. (1994) Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes. 43: 357368.
  • 282
    Moller, D. E., Cohen, O., Yamaguchi, Y., et al (1994) Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes. 43: 247255.
  • 283
    Shimada, F., Taira, M., Suzuki, Y., et al (1990) Insulin-resistant diabetes associated with partial deletion of insulin- receptor gene. Lancet. 335: 11791181.
  • 284
    Shimada, F., Suzuki, Y., Taira, M., et al (1992) Abnormal messenger ribonucleic acid (mRNA) transcribed from a mutant insulin receptor gene in a patient with type A insulin resistance. Diabetologia. 35: 639644.
  • 285
    Wertheimer, E., Litvin, Y., Ebstein, R. P., et al (1994) Deletion of exon 3 of the insulin receptor gene in a kindred with a familial form of insulin resistance. J Clin Endocrinol Metab. 78: 11531158.
  • 286
    Biswas, S., Munier, F. L., Yardley, J., et al (2001) Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet. 10: 24152423.
  • 287
    Heon, E., Mathers, W. D., Alward, W. L., et al (1995) Linkage of posterior polymorphous corneal dystrophy to 20q11. Hum Mol Genet. 4: 485488.
  • 288
    Boccaccio, I., Glatt-Deeley, H., Watrin, F., Roeckel, N., Lalande, M., Muscatelli, F. (1999) The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region. Hum Mol Genet. 8: 24972505.
  • 289
    de los Santos, T., Schweizer, J., Rees, C. A., Francke, U. (2000) Small evolutionarily conserved RNA, resembling C/D box small nucleolar RNA, is transcribed from PWCR1, a novel imprinted gene in the Prader-Willi deletion region, which is highly expressed in brain. Am J Hum Genet. 67: 10671082.
  • 290
    Gallagher, R. C., Pils, B., Albalwi, M., Francke, U. (2002) Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader-Willi syndrome. Am J Hum Genet. 71: 669678.
  • 291
    Gilhuis, H. J., van Ravenswaaij, C. M., Hamel, B. J., Gabreels, FJ. (2000) Interstitial 6q deletion with a Prader-Willi-like phenotype: a new case and review of the literature. Eur J Paediatr Neurol. 4: 3943.
  • 292
    Hordijk, R., Wierenga, H., Scheffer, H., Leegte, B., Hofstra, R. M., Stolte-Dijkstra, I. (1999) Maternal uniparental disomy for chromosome 14 in a boy with a normal karyotype. J Med Genet. 36: 782785.
  • 293
    Jay, P., Rougeulle, C., Massacrier, A., et al (1997) The human necdin gene NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nat Genet. 17: 357361.
  • 294
    Jong, M. T., Gray, T. A., Ji, Y., et al (1999) A novel imprinted gene, encoding a RING zinc-finger protein, and overlapping antisense transcript in the Prader-Willi syndrome critical region. Hum Mol Genet. 8: 783793.
  • 295
    Kuslich, C. D., Kobori, J. A., Mohapatra, G., Gregorio-King, C., Donlon, TA. (1999) Prader-Willi syndrome is caused by disruption of the SNRPN gene. Am J Hum Genet. 64: 7076.
  • 296
    Lee, S., Kozlov, S., Hernandez, L., et al (2000) Expression and imprinting of MAGEL2 suggest a role in Prader-Willi syndrome and the homologous murine imprinting phenotype. Hum Mol Genet. 9: 18131819.
  • 297
    Meguro, M., Mitsuya, K., Nomura, N., et al (2001) Large-scale evaluation of imprinting status in the Prader-Willi syndrome region: an imprinted direct repeat cluster resembling small nucleolar RNA genes. Hum Mol Genet. 10: 383394.
  • 298
    Ming, J. E., Blagowidow, N., Knoll, J. H., et al (2000) Submicroscopic deletion in cousins with Prader-Willi syndrome causes a grandmatrilineal inheritance pattern: effects of imprinting. Am J Med Genet. 92: 1924.
  • 299
    Ohta, T., Gray, T. A., Rogan, P. K., et al (1999) Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet. 64: 397413.
  • 300
    Robinson, W. P., Bottani, A., Xie, Y. G., et al (1991) Molecular, cytogenetic, and clinical investigations of Prader-Willi syndrome patients. Am J Hum Genet. 49: 12191234.
  • 301
    Stein, C. K., Stred, S. E., Thomson, L. L., Smith, F. C., Hoo, JJ. (1996) Interstitial 6q deletion and Prader-Willi-like phenotype. Clin Genet. 49: 306310.
  • 302
    Turleau, C., Demay, G., Cabanis, M. O., Lenoir, G., de Grouchy, J. (1988) 6q1 monosomy: a distinctive syndrome. Clin Genet. 34: 3842.
  • 303
    Wevrick, R., Kerns, J. A., Francke, U. (1994) Identification of a novel paternally expressed gene in the Prader-Willi syndrome region. Hum Mol Genet. 3: 18771882.
  • 304
    Wirth, J., Back, E., Huttenhofer, A., et al (2001) A translocation breakpoint cluster disrupts the newly defined 3′ end of the SNURF-SNRPN transcription unit on chromosome 15. Hum Mol Genet. 10: 201210.
  • 305
    Villa, A., Urioste, M., Bofarull, J. M., Martinez-Frias, ML. (1995) De novo interstitial deletion q16.2q21 on chromosome 6. Am J Med Genet. 55: 379383.
  • 306
    Holder, J. L. Jr, Butte, N. F., Zinn, AR. (2000) Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum Mol Genet. 9: 101108.
  • 307
    Roland, B., Lowry, R. B., Cox, D. M., Ferreira, P., Lin, CC. (1993) Familial complex chromosomal rearrangement resulting in duplication/deletion of 6q14 to 6q16. Clin Genet. 43: 117121.
  • 308
    Smith, A. (1999) The diagnosis of Prader-Willi syndrome. J Paediatr Child Health. 35: 335337.
  • 309
    Faivre, L., Cormier-Daire, V., Lapierre, J. M., et al (2002) Deletion of the SIM1 gene (6q16.2) in a patient with a Prader-Willi-like phenotype. J Med Genet. 39: 594596.
  • 310
    Bamshad, M., Lin, R. C., Law, D. J., et al (1997) Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome. Nat Genet. 16: 311315.
  • 311
    Behr, M., Ramsden, D. B., Loos, U. (1997) Deoxyribonucleic acid binding and transcriptional silencing by a truncated c-erbAB1 thyroid hormone receptor identified in a severely retarded patient with resistance to thyroid hormone. J Clin Endocrinol Metab. 82: 10811087.
  • 312
    Bamshad, M., Le, T., Watkins, W. S., et al (1999) The spectrum of mutations in TBX3: Genotype/Phenotype relationship in ulnar-mammary syndrome. Am J Hum Genet. 64: 15501562.
  • 313
    Gul, D., Ogur, G., Tunca, Y., Ozcan, O. (2002) Third case of WAGR syndrome with severe obesity and constitutional deletion of chromosome (11)(p12p14). Am J Med Genet. 107: 7071.
  • 314
    Marlin, S., Couet, D., Lacombe, D., Cessans, C., Bonneau, D. (1994) Obesity: a new feature of WAGR (del 11p) syndrome. Clin Dysmorphol. 3: 255257.
  • 315
    Tiberio, G., Digilio, M. C., Giannotti, A. (2000) Obesity and WAGR syndrome. Clin Dysmorphol. 9: 6364.
  • 316
    Gecz, J., Baker, E., Donnelly, A., et al (1999) Fibroblast growth factor homologous factor 2 (FHF2): gene structure, expression and mapping to the Borjeson-Forssman-Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS-like patient. Hum Genet. 104: 5663.
  • 317
    Kubota, T., Oga, S., Ohashi, H., Iwamoto, Y., Fukushima, Y. (1999) Borjeson-Forssman-Lehmann syndrome in a woman with skewed X-chromosome inactivation. Am J Med Genet. 87: 258261.
  • 318
    Lower, K. M., Turner, G., Kerr, B. A., et al (2002) Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome. Nat Genet. 32: 661665.
  • 319
    Merry, D. E., Lesko, J. G., Sosnoski, D. M., et al (1989) Choroideremia and deafness with stapes fixation: a contiguous gene deletion syndrome in Xq21. Am J Hum Genet. 45: 530540.
  • 320
    Schwartz, M., Yang, H. M., Niebuhr, E., Rosenberg, T., Page, DC. (1988) Regional localization of polymorphic DNA loci on the proximal long arm of the X chromosome using deletions associated with choroideremia. Hum Genet. 78: 156160.
  • 321
    Leshinsky-Silver, E., Zinger, A., Bibi, C. N., et al (2002) MEHMO (Mental retardation, Epileptic seizures, Hypogenitalism, Microcephaly, Obesity): a new X-linked mitochondrial disorder. Eur J Hum Genet. 10: 226230.
  • 322
    Steinmuller, R., Steinberger, D., Muller, U. (1998) MEHMO (mental retardation, epileptic seizures, hypogonadism and -genitalism, microcephaly, obesity), a novel syndrome: assignment of disease locus to Xp21.1-p22.13. Eur J Hum Genet. 6: 201206.
  • 323
    DeLozier-Blanchet, C. D., Haenggeli, C. A., Bottani, A. (1999) MEHMO, a novel syndrome: assignment of disease locus to Xp21.1-p22.13. Mental retardation, epileptic seizures, hypogonadism and genitalism, microcephaly, obesity. Eur J Hum Genet. 7: 621622.
  • 324
    Ahmad, W., De Fusco, M., ul Haque, M. F., et al (1999) Linkage mapping of a new syndromic form of X-linked mental retardation, MRXS7, associated with obesity. Eur J Hum Genet. 7: 828832.
  • 325
    Shashi, V., Berry, M. N., Shoaf, S., Sciote, J. J., Goldstein, D., Hart, TC. (2000) A unique form of mental retardation with a distinctive phenotype maps to Xq26–q27. Am J Hum Genet. 66: 469479. [Published erratum in Am J Hum Genet. 2000;66:1472].
  • 326
    Monaghan, K. G., Van Dyke, D. L., Feldman, GL. (1998) Prader-Willi-like syndrome in a patient with an Xq23q25 duplication. Am J Med Genet. 80: 227231.
  • 327
    Hughes-Benzie, R. M., Pilia, G., Xuan, J. Y., et al (1996) Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families. Am J Med Genet. 66: 227234.
  • 328
    Lindsay, S., Ireland, M., O'Brien, O., et al (1997) Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome. J Med Genet. 34: 480483.
  • 329
    Neri, G., Gurrieri, F., Zanni, G., Lin, A. (1998) Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome. Am J Med Genet. 79: 279283.
  • 330
    Okamoto, N., Yagi, M., Imura, K., Wada, Y. (1999) A clinical and molecular study of a patient with Simpson-Golabi-Behmel syndrome. J Hum Genet. 44: 327329.
  • 331
    Veugelers, M., Vermeesch, J., Watanabe, K., Yamaguchi, Y., Marynen, P., David, G. (1998) GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome. Genomics. 53: 111.
  • 332
    Veugelers, M., Cat, B. D., Muyldermans, S. Y., et al (2000) Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene. Hum Mol Genet. 9: 13211328.
  • 333
    Xuan, J. Y., Hughes-Benzie, R. M., MacKenzie, AE. (1999) A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family. J Med Genet. 36: 5758.
  • 334
    Brzustowicz, L. M., Farrell, S., Khan, M. B., Weksberg, R. (1999) Mapping of a new SGBS locus to chromosome Xp22 in a family with a severe form of Simpson-Golabi-Behmel syndrome. Am J Hum Genet. 65: 779783.
  • 335
    Gedeon, A., Mulley, J., Turner, G. (1996) Gene localisation for Wilson-Turner syndrome (WTS:MIM 309585). Am J Med Genet. 64: 8081.
  • 336
    Wilson, M., Mulley, J., Gedeon, A., Robinson, H., Turner, G. (1991) New X-linked syndrome of mental retardation, gynecomastia, and obesity is linked to DXS255. Am J Med Genet. 40: 406413.
  • 337
    Chen, H., Charlat, O., Tartaglia, L. A., et al (1996) Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 84: 491495.
  • 338
    Tartaglia, L. A., Dembski, M., Weng, X., et al (1995) Identification and expression cloning of a leptin receptor, OB-R. Cell. 83: 12631271.
  • 339
    Peterfy, M., Phan, J., Xu, P., Reue, K. (2001) Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat Genet. 27: 121124.
  • 340
    Naggert, J. K., Fricker, L. D., Varlamov, O., et al (1995) Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet. 10: 135142.
  • 341
    Fumakoshi, A., Shinozaki, H., Masada, M., et al (1993) An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor. Biochem Biophys Res Commun. 210: 787796.
  • 342
    Schwartz, G. J., Whitney, A., Skoglund, C., Castonguay, T. W., Moran, TH. (1999) Decreased responsiveness to dietary fat in Otsuka Long-Evans Tokushima fatty rats lacking CCK-A receptors. Am J Physiol. 277: R1144R1151.
  • 343
    Donahue, L. R., Beamer, WG. (1993) Growth hormone deficiency in ‘little’ mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, −1 or −4. J Endocrinol. 136: 91104.
  • 344
    Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, JM. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature. 372: 425432.
  • 345
    Kapeller, R., Moriarty, A., Strauss, A., et al (1999) Tyrosine phosphorylation of tub and its association with Src homology 2 domain-containing proteins implicate tub in intracellular signaling by insulin. J Biol Chem. 274: 2498024986.
  • 346
    Kleyn, P. W., Fan, W., Kovats, S. G., et al (1996) Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell. 85: 281290.
  • 347
    Noben-Trauth, K., Naggert, J. K., North, M. A., Nishina, PM. (1996) A candidate gene for the mouse mutation tubby. Nature. 380: 534538.
  • 348
    Nagle, D. L., McGrail, S. H., Vitale, J., et al (1999) The mahogany protein is a receptor involved in suppression of obesity. Nature. 398: 148152.
  • 349
    Gunn, T. M., Miller, K. A., He, L., et al (1999) The mouse mahogany locus encodes a transmembrane form of human attractin. Nature. 398: 152156.
  • 350
    Wilson, B. D., Ollmann, M. M., Kang, L., Stoffel, M., Bell, G. I., Barsh, GS. (1995) Structure and function of ASP, the human homolog of the mouse agouti gene. Hum Mol Genet. 4: 223230.
  • 351
    Abu-Elheiga, L., Matzuk, M. M., Abo-Hashema, K. A., Wakil, SJ. (2001) Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science. 291: 26132616.
  • 352
    Jong, M. C., Voshol, P. J., Muurling, M., et al (2001) Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1. Diabetes. 50: 27792785.
  • 353
    Moitra, J., Mason, M. M., Olive, M., et al (1998) Life without white fat: a transgenic mouse. Genes Dev. 12: 31683181.
  • 354
    Ohki-Hamazaki, H., Watase, K., Yamamoto, K., et al (1997) Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature. 390: 165169.
  • 355
    Murray, I., Havel, P. J., Sniderman, A. D., Cianflone, K. (2000) Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology. 141: 10411049.
  • 356
    Wang, N. D., Finegold, M. J., Bradley, A., et al (1995) Impaired energy homeostasis in C/EBP alpha knockout mice. Science. 269: 11081112.
  • 357
    Tanaka, T., Yoshida, N., Kishimoto, T., Akira, S. (1997) Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. Embo J. 16: 74327443.
  • 358
    Yamada, M., Miyakawa, T., Duttaroy, A., et al (2001) Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature. 410: 207212.
  • 359
    Jones, M. E., Thorburn, A. W., Britt, K. L., et al (2000) Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A. 97: 1273512740.
  • 360
    Kozak, L. P., Kozak, U. C., Clarke, GT. (1991) Abnormal brown and white fat development in transgenic mice overexpressing glycerol 3-phosphate dehydrogenase. Genes Dev. 5: 22562264.
  • 361
    Zhou, Q. Y., Palmiter, RD. (1995) Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell. 83: 11971209.
  • 362
    Hotamisligil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., Spiegelman, BM. (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science. 274: 13771379.
  • 363
    Smith, S. J., Cases, S., Jensen, D. R., et al (2000) Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet. 25: 8790.
  • 364
    Danilovich, N., Babu, P. S., Xing, W., Gerdes, M., Krishnamurthy, H., Sairam, MR. (2000) Estrogen deficiency, obesity, and skeletal abnormalities in follicle- stimulating hormone receptor knockout (FORKO) female mice. Endocrinology. 141: 42954308.
  • 365
    Ma, Y. H., Hu, J. H., Zhou, X. G., et al (2000) Transgenic mice overexpressing gamma-aminobutyric acid transporter subtype I develop obesity. Cell Res. 10: 303310.
  • 366
    Tsukiyama-Kohara, K., Poulin, F., Kohara, M., et al (2001) Adipose tissue reduction in mice lacking the translational inhibitor 4E- BP1. Nat Med. 7: 11281132.
  • 367
    Cai, A., Hyde, JF. (1999) The human growth hormone-releasing hormone transgenic mouse as a model of modest obesity: differential changes in leptin receptor (OBR) gene expression in the anterior pituitary and hypothalamus after fasting and OBR localization in somatotrophs. Endocrinology. 140: 36093614.
  • 368
    Marsh, D. J., Weingarth, D. T., Novi, D. E., et al (2002) Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci U S A. 99: 32403245.
  • 369
    Masaki, T., Yoshimatsu, H., Chiba, S., Watanabe, T., Sakata, T. (2001) Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice. Diabetes. 50: 385391.
  • 370
    Hara, J., Beuckmann, C. T., Nambu, T., et al (2001) Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 30: 345354.
  • 371
    Fain, J. N., Del Mar, N. A., Meade, C. A., Reiner, A., Goldowitz, D. (2001) Abnormalities in the functioning of adipocytes from R6/2 mice that are transgenic for the Huntington's disease mutation. Hum Mol Genet. 10: 145152.
  • 372
    Anand, A., Chada, K. (2000) In vivo modulation of Hmgic reduces obesity. Nat Genet. 24: 377380.
  • 373
    Masuzaki, H., Paterson, J., Shinyama, H., et al (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science. 294: 21662170.
  • 374
    Dong, Z. M., Gutierrez-Ramos, J. C., Coxon, A., Mayadas, T. N., Wagner, DD. (1997) A new class of obesity genes encodes leukocyte adhesion receptors. Proc Natl Acad Sci U S A. 94: 75267530.
  • 375
    Hirsch, E., Irikura, V. M., Paul, S. M., Hirsh, D. (1996) Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci U S A. 93: 1100811013.
  • 376
    Beattie, J. H., Wood, A. M., Newman, A. M., et al (1998) Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Proc Natl Acad Sci U S A. 95: 358363.
  • 377
    Good, D. J., Porter, F. D., Mahon, K. A., Parlow, A. F., Westphal, H., Kirsch, IR. (1997) Hypogonadism and obesity in mice with a targeted deletion of the Nhlh2 gene. Nat Genet. 15: 397401.
  • 378
    Cummings, D. E., Brandon, E. P., Planas, J. V., Motamed, K., Idzerda, R. L., McKnight, GS. (1996) Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A. Nature. 382: 622626.
  • 379
    Martinez-Botas, J., Anderson, J. B., Tessier, D., et al (2000) Absence of perilipin results in leanness and reverses obesity in Lepr(db/db) mice. Nat Genet. 26: 474479.
  • 380
    Tansey, J. T., Sztalryd, C., Gruia-Gray, J., et al (2001) Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A. 98: 64946499.
  • 381
    Ludwig, D. S., Tritos, N. A., Mastaitis, J. W., et al (2001) Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest. 107: 379386.
  • 382
    Shimada, M., Tritos, N. A., Lowell, B. B., Flier, J. S., Maratos-Flier, E. (1998) Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature. 396: 670674.
  • 383
    Ueno, N., Inui, A., Iwamoto, M., et al (1999) Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice. Gastroenterology. 117: 14271432.
  • 384
    Elchebly, M., Payette, P., Michaliszyn, E., et al (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 283: 15441548.
  • 385
    Reizes, O., Lincecum, J., Wang, Z., et al (2001) Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3. Cell. 106: 105116.
  • 386
    Shimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., Goldstein, JL. (1996) Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest. 98: 15751584.
  • 387
    Shimomura, I., Hammer, R. E., Richardson, J. A., et al (1998) Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12: 31823194.
  • 388
    Udy, G. B., Towers, R. P., Snell, R. G., et al (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A. 94: 72397244.
  • 389
    Clouthier, D. E., Comerford, S. A., Hammer, RE. (1997) Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. J Clin Invest. 100: 26972713.
  • 390
    Hahm, S., Mizuno, T. M., Wu, T. J., et al (1999) Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron. 23: 537548.
  • 391
    Dragani, T. A., Zeng, Z. B., Canzian, F., et al (1995) Mapping of body weight loci on mouse chromosome X. Mamm Genome. 6: 778781.
  • 392
    Taylor, B. A., Phillips, SJ. (1996) Detection of obesity QTLs on mouse chromosomes 1 and 7 by selective DNA pooling. Genomics. 34: 389398.
  • 393
    Taylor, B. A., Phillips, SJ. (1997) Obesity QTLs on mouse chromosome 2 and 17. Genomics. 43: 249257.
  • 394
    West, D. B., Goudey-Lefevre, J., York, B., Truett, GE. (1994) Dietary obesity linked to genetic loci on chromosomes 9 and 15 in a polygenic mouse model. J Clin Invest. 94: 14101416.
  • 395
    West, D. B., Waguespack, J., York, B., Goudey-Lebevre, J., Price, RA. (1994) Genetics of dietary obesity in AKR/J x SWR/J mice: segregation of the trait and identification of a linked locus on chromosome 4. Mamm Genome. 5: 546552.
  • 396
    Mehrabian, M., Wen, P., Fisler, J., Davis, R., Lusis, A. (1998) Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model. J Clin Invest. 101: 24852496.
  • 397
    Pomp, D. (1997) Genetic dissection of obesity in polygenic animal models. Behav Genet. 27: 285306.
  • 398
    Corva, P. M., Horvat, S., Medrano, JF. (2001) Quantitative trait loci affecting growth in high growth (hg) mice. Mamm Genome. 12: 284290.
  • 399
    Keightley, P. D., Hardge, T., May, L., Bulfield, G. (1996) A genetic map of quantitative trait loci for body weight in the mouse. Genetics. 142: 227235.
  • 400
    Keightley, P. D., Morris, K. H., Ishikawa, A., Falconer, V. M., Oliver, F. (1998) Test of candidate gene-quantitative trait locus association applied to fatness in mice. Heredity. 81: 630637.
  • 401
    Brockmann, G., Timtchenko, D., Das, P., et al (1996) Detection of QTL for body weight and body fat content in mice using genetic markers. J Anim Breed Genet. 113: 373379.
  • 402
    Brockmann, G. A., Haley, C. S., Renne, U., Knott, S. A., Schwerin, M. (1998) Quantitative trait loci affecting body weight and fatness from a mouse line selected for extreme high growth. Genetics. 150: 369381.
  • 403
    Brockmann, G. A., Kratzsch, J., Haley, C. S., Renne, U., Schwerin, M., Karle, S. (2000) Single QTL effects, epistasis, and pleiotropy account for two-thirds of the phenotypic F(2) variance of growth and obesity in DU6i x DBA/2 mice. Genome Res. 10: 19411957.
  • 404
    Horvat, S., Bunger, L., Falconer, V., et al (2000) Mapping of obesity QTLs in a cross between mouse lines divergently selected on fat content. Mamm Genome. 11: 27.
  • 405
    Suto, J., Matsuura, S., Imamura, K., Yamanaka, H., Sekikawa, K. (1998) Genetics of obesity in KK mouse and effects of A(y) allele on quantitative regulation. Mamm Genome. 9: 506510.
  • 406
    Taylor, B. A., Tarantino, L. M., Phillips, SJ. (1999) Gender-influenced obesity QTLs identified in a cross involving the KK type II diabetes-prone mouse strain. Mamm Genome. 10: 963968.
  • 407
    Moody, D. E., Pomp, D., Nielsen, M. K., Van Vleck, LD. (1999) Identification of quantitative trait loci influencing traits related to energy balance in selection and inbred lines of mice. Genetics. 152: 699711.
  • 408
    Warden, C. H., Fisler, J. S., Shoemaker, S. M., et al (1995) Identification of four chromosomal loci determining obesity in a multifactorial mouse model. J Clin Invest. 95: 15451552.
  • 409
    Ueda, H., Ikegami, H., Kawaguchi, Y., et al (1999) Genetic analysis of late-onset type 2 diabetes in a mouse model of human complex trait. Diabetes. 48: 11681174.
  • 410
    Lembertas, A. V., Perusse, L., Chagnon, Y. C., et al (1997) Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest. 100: 12401247.
  • 411
    Kluge, R., Giesen, K., Bahrenberg, G., Plum, L., Ortlepp, J. R., Joost, HG. (2000) Quantitative trait loci for obesity and insulin resistance (Nob1, Nob2) and their interaction with the leptin receptor allele (LeprA720T/T1044I) in New Zealand obese mice. Diabetologia. 43: 15651572.
  • 412
    Taylor, B. A., Wnek, C., Schroeder, D., Phillips, SJ. (2001) Multiple obesity QTLs identified in an intercross between the NZO (New Zealand obese) and the SM (small) mouse strains. Mamm Genome. 12: 95103.
  • 413
    Reifsnyder, P. C., Churchill, G., Leiter, EH. (2000) Maternal environment and genotype interact to establish diabesity in mice. Genome Res. 10: 15681578.
  • 414
    Collins, A. C., Martin, I. C. A., Kirkpatrick, BW. (1993) Growth quantitative trait loci (QTL) on mouse chromosome 10 in a Quackenbush-Swiss x C57BL/6J backcross. Mamm Genome. 4: 454458.
  • 415
    Anunciado, R. V., Nishimura, M., Mori, M., et al (2001) Quantitative trait loci for body weight in the intercross between SM/J and A/J mice. Exp Anim. 50: 319324.
  • 416
    Cheverud, J. M., Routman, E. J., Duarte, F. A., van Swinderen, B., Cothran, K., Perel, C. (1996) Quantitative trait loci for murine growth. Genetics. 142: 13051319.
  • 417
    Cheverud, J. M., Vaughn, T. T., Pletscher, L. S., et al (2001) Genetic architecture of adiposity in the cross of LG/J and SM/J inbred mice. Mamm Genome. 12: 312.
  • 418
    Vaughn, T. T., Pletscher, L. S., Peripato, A., et al (1999) Mapping quantitative trait loci for murine growth: a closer look at genetic architecture. Genet Res. 74: 313322.
  • 419
    Hirayama, I., Yi, Z., Izumi, S., et al (1999) Genetic analysis of obese diabetes in the TSOD mouse. Diabetes. 48: 11831191.
  • 420
    Ishikawa, A., Matsuda, Y., Namikawa, T. (2000) Detection of quantitative trait loci for body weight at 10 weeks from Philippine wild mice. Mamm Genome. 11: 824830.
  • 421
    Watanabe, T., Okuno, S., Oga, K., et al (1999) Genetic dissection of “OLETF,” a rat model for non-insulin-dependent diabetes mellitus: quantitative trait locus analysis of (OLETF x BN) x OLETF. Genomics. 58: 233239.
  • 422
    Kato, N., Hyne, G., Bihoreau, M. T., Gauguier, D., Lathrop, G. M., Rapp, JP. (1999) Complete genome searches for quantitative trait loci controlling blood pressure and related traits in four segregating populations derived from Dahl hypertensive rats. Mamm Genome. 10: 259265.
  • 423
    Gauguier, D., Froguel, P., Parent, V., et al (1996) Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. Nat Genet. 12: 3843.
  • 424
    Galli, J., Li, L. S., Glaser, A., et al (1996) Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. Nat Genet. 12: 3137.
  • 425
    Chung, W. K., Zheng, M., Chua, M., et al (1997) Genetic modifiers of Leprfa associated with variability in insulin production and susceptibility to NIDDM. Genomics. 41: 332344.
  • 426
    Kanemoto, N., Hishigaki, H., Miyakita, A., et al (1998) Genetic dissection of “OLETF”, a rat model for non-insulin-dependent diabetes mellitus. Mamm Genome. 9: 419425.
  • 427
    Ogino, T., Wei, S., Wei, K., et al (2000) Genetic evidence for obesity loci involved in the regulation of body fat distribution in obese type 2 diabetes rat, OLETF. Genomics. 70: 1925.
  • 428
    Tanomura, H., Miyake, T., Taniguchi, Y., et al (2002) Detection of a quantitative trait locus for intramuscular fat accumulation using the OLETF rat. J Vet Med Sci. 64: 4550.
  • 429
    Kovacs, P., Kloting, I. (1998) Mapping of quantitative trait loci for body weight on chromosomes 1 and 4 in the rat. Biochem Mol Biol Int. 44: 399405.
  • 430
    Kloting, I., Kovacs, P., van den Brandt, J. (2001) Quantitative trait loci for body weight, blood pressure, blood glucose, and serum lipids: linkage analysis with wild rats (Rattus norvegicus). Biochem Biophys Res Commun. 284: 11261133.
  • 431
    Kloting, I., Kovacs, P., van den Brandt, J. (2001) Sex-specific and sex-independent quantitative trait loci for facets of the metabolic syndrome in WOKW rats. Biochem Biophys Res Commun. 284: 150156.
  • 432
    Malek, M., Dekkers, J. C., Lee, H. K., et al (2001) A molecular genome scan analysis to identify chromosomal regions influencing economic traits in the pig. II. Meat and muscle composition. Mamm Genome. 12: 637645.
  • 433
    Anderson, L., Haley, C. S., Ellegren, H., et al (1994) Genetic mapping of quantitative trait loci for growth and fatness in pigs. Science. 263: 17711774.
  • 434
    Knott, S. A., Marklund, L., Haley, C. S., et al (1998) Multiple marker mapping of quantitative trait loci in a cross between outbred wild boar and large white pigs. Genetics. 149: 10691080.
  • 435
    Marklund, L., Nystrom, P. E., Stern, S., Andersson-Eklund, L., Andersson, L. (1999) Confirmed quantitative trait loci for fatness and growth on pig chromosome 4. Heredity. 82: 134141.
  • 436
    Perez-Enciso, M., Clop, A., Noguera, J. L., et al (2000) A QTL on pig chromosome 4 affects fatty acid metabolism: evidence from an Iberian by Landrace intercross. J Anim Sci. 78: 25252531.
  • 437
    Rattink, A. P., de Koning, D. J., Faivre, M., Harlizius, B., van Arendonk, J. A., Groenen, MA. (2000) Fine mapping and imprinting analysis for fatness trait QTLs in pigs. Mamm Genome. 11: 656661.
  • 438
    de Koning, D. J., Janss, L. L., Rattink, A. P., et al (1999) Detection of quantitative trait loci for backfat thickness and intramuscular fat content in pigs (Sus scrofa). Genetics. 152: 16791690.
  • 439
    Rothschild, M. F., Liu, H. C., Tuggle, C. K., Yu, T. P., Wang, L. (1995) Analysis of pig chromosome 7 genetic markers for growth and carcass performance traits. J Anim Breed Genet. 112: 341348.
  • 440
    Wang, L., Yu, T. P., Tuggle, C. K., Liu, H. C., Rothschild, MF. (1998) A directed search for quantitative trait loci on chromosomes 4 and 7 in pigs. J Anim Sci. 76: 25602567.
  • 441
    de Koning, D. J., Rattink, A. P., Harlizius, B., van Arendonk, J. A., Brascamp, E. W., Groenen, MA. (2000) Genome-wide scan for body composition in pigs reveals important role of imprinting. Proc Natl Acad Sci U S A. 97: 79477950.
  • 442
    Harlizius, B., Rattink, A., Faivre, M., et al (2000) The X chromosome harbors quantitative trait loci for backfat thickness and intramuscular fat content in pigs. Mamm Genome. 11: 800802.
  • 443
    Wada, Y., Akita, T., Awata, T., et al (2000) Quantitative trait loci (QTL) analysis in a Meishan x Gottingen cross population. Anim Genet. 31: 376384.
  • 444
    Walling, G. A., Archibald, A. L., Cattermole, J. A., et al (1998) Mapping of quantitative trait loci on porcine chromosome 4. Anim Genet. 29: 415424.
  • 445
    Bidanel, J. P., Milan, D., Iannuccelli, N., et al (2001) Detection of quantitative trait loci for growth and fatness in pigs. Genet Sel Evol. 33: 289309.
  • 446
    Rohrer, GA. (2000) Identification of quantitative trait loci affecting birth characters and accumulation of backfat and weight in a Meishan-White composite resource population. J Anim Sci. 78: 25472553.
  • 447
    Rohrer, G. A., Keele, JW. (1998) Identification of quantitative trait loci affecting carcass composition in swine. I. Fat deposition traits. J Anim Sci. 76: 22472254.
  • 448
    Jeon, J. T., Carlborg, O., Tornsten, A., et al (1999) A paternally expressed QTL affecting skeletal and cardiac muscle mass in pigs maps to the IGF2 locus. Nat Genet. 21: 157158.
  • 449
    Nezer, C., Moreau, L., Brouwers, B., et al (1999) An imprinted QTL with major effect on muscle mass and fat deposition maps to the IGF2 locus in pigs. Nat Genet. 21: 155156.
  • 450
    MacNeil, M. D., Grosz, MD. (2002) Genome-wide scans for QTL affecting carcass traits in Hereford x composite double backcross populations. J Anim Sci. 80: 23162324.
  • 451
    York, B., Lei, K., West, DB. (1996) Sensitivity to dietary obesity linked to a locus on chromosome 15 in a CAST/Ei x C57B1/6J F2 intercross. Mamm Genome. 7: 677681.
  • 452
    Jacob, H. J., Brown, D. M., Bunker, R. K., et al (1995) A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet. 9: 6369.
  • 453
    Hani, E. H., Clement, K., Velho, G., et al (1997) Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians. Diabetes. 46: 688694.
  • 454
    Lucarini, N., Finocchi, G., Gloria-Bottini, F., et al (1990) A possible genetic component of obesity in childhood. Observations on acid phosphatase polymorphism. Experientia. 46: 9091.
  • 455
    Lucarini, N., Antonacci, E., Bottini, N., Gloria-Bottini, F. (1997) Low-molecular-weight acid phosphatase (ACP1), obesity, and blood lipid levels in subjects with non-insulin-dependent diabetes mellitus. Hum Biol. 69: 509515.
  • 456
    Bottini, E., Gloria-Bottini, F. (1999) Adenosine deaminase and body mass index in non-insulin-dependent diabetes mellitus. Metabolism. 48: 949951.
  • 457
    Garenc, C., Perusse, L., Chagnon, Y. C., et al (2002) The alpha 2-adrenergic receptor gene and body fat content and distribution: the HERITAGE Family Study. Mol Med. 8: 8894.
  • 458
    Oppert, J. M., Tourville, J., Chagnon, M., et al (1995) DNA polymorphisms in alpha 2- and beta 2-adrenoceptor genes and regional fat distribution in humans: association and linkage studies. Obes Res. 3: 249255.
  • 459
    Heinonen, P., Koulu, M., Pesonen, U., et al (1999) Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J Clin Endocrinol Metab. 84: 24292433.
  • 460
    Sivenius, K., Lindi, V., Niskanen, L., Laakso, M., Uusitupa, M. (2001) Effect of a three-amino acid deletion in the alpha2B-adrenergic receptor gene on long-term body weight change in Finnish non-diabetic and type 2 diabetic subjects. Int J Obes Relat Metab Disord. 25: 16091614.
  • 461
    Dionne, I. J., Garant, M. J., Nolan, A. A., et al (2002) Association between obesity and a polymorphism in the beta(1)-adrenoceptor gene (Gly389Arg ADRB1) in Caucasian women. Int J Obes Relat Metab Disord. 26: 633639.
  • 462
    Corbalan, M. S., Marti, A., Forga, L., Martinez-Gonzalez, M. A., Martinez, JA. (2002) The risk of obesity and the Trp64Arg polymorphism of the beta(3)-adrenergic receptor: effect modification by age. Ann Nutr Metab. 46: 152158.
  • 463
    Ehrenborg, E., Skogsberg, J., Ruotolo, G., et al (2000) The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins. J Intern Med. 247: 651656.
  • 464
    Ellsworth, D. L., Coady, S. A., Chen, W., et al (2002) Influence of the beta2-adrenergic receptor Arg16Gly polymorphism on longitudinal changes in obesity from childhood through young adulthood in a biracial cohort: the Bogalusa Heart Study. Int J Obes Relat Metab Disord. 26: 928937.
  • 465
    Hoffstedt, J., Iliadou, A., Pedersen, N. L., Schalling, M., Arner, P. (2001) The effect of the beta(2) adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function. Br J Pharmacol. 133: 708712.
  • 466
    Ishiyama-Shigemoto, S., Yamada, K., Yuan, X., Ichikawa, F., Nonaka, K. (1999) Association of polymorphisms in the beta 2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia. 42: 98101.
  • 467
    Large, V., Hellstrom, L., Reynisdottir, S., et al (1997) Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest. 100: 30053013.
  • 468
    Meirhaeghe, A., Helbecque, N., Cottel, D., Amouyel, P. (2000) Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population. Int J Obes Relat Metab Disord. 24: 382387.
  • 469
    Meirhaeghe, A., Luan, J., Selberg-Franks, P., et al (2001) The effect of the Gly16Arg polymorphism of the beta(2)-adrenergic receptor gene on plasma free fatty acid levels is modulated by physical activity. J Clin Endocrinol Metab. 86: 58815887.
  • 470
    Meirhaeghe, A., Helbecque, N., Cottel, D., Amouyel, P. (1999) Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet. 353: 896
  • 471
    Moore, G. E., Shuldiner, A. R., Zmuda, J. M., Ferrell, R. E., McCole, S. D., Hagberg, JM. (2001) Obesity gene variant and elite endurance performance. Metabolism. 50: 13911392.
  • 472
    Mori, Y., Kim-Motoyama, H., Ito, Y., et al (1999) The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun. 258: 138140.
  • 473
    Rosmond, R., Ukkola, O., Chagnon, M., Bouchard, C., Björntorp, P. (2000) Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. J Intern Med. 248: 239244.
  • 474
    Ukkola, O., Rankinen, T., Weisnagel, S. J., et al (2000) Interactions among the alpha2-, beta2-, and beta3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism. 49: 10631070.
  • 475
    Ukkola, O., Tremblay, A., Bouchard, C. (2001) Beta-2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding. Int J Obes Relat Metab Disord. 25: 16041608.
  • 476
    van Rossum, C. T., Hoebee, B., Seidell, J. C., et al (2002) Genetic factors as predictors of weight gain in young adult Dutch men and women. Int J Obes Relat Metab Disord. 26: 517528.
  • 477
    Yamada, K., Ishiyama-Shigemoto, S., Ichikawa, F., et al (1999) Polymorphism in the 5′-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes. J Clin Endocrinol Metab. 84: 17541757.
  • 478
    Clement, K., Vaisse, C., Manning, B. S. J., et al (1995) Genetic variation in the B3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med. 333: 352354.
  • 479
    Corella, D., Guillen, M., Portoles, O., et al (2001) Gender specific associations of the Trp64Arg mutation in the beta3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation. J Intern Med. 250: 348360.
  • 480
    Endo, K., Yanagi, H., Hirano, C., Hamaguchi, H., Tsuchiya, S., Tomura, S. (2000) Association of Trp64Arg polymorphism of the beta3-adrenergic receptor gene and no association of Gln223Arg polymorphism of the leptin receptor gene in Japanese schoolchildren with obesity. Int J Obes Relat Metab Disord. 24: 443449.
  • 481
    Festa, A., Krugluger, W., Shnawa, N., Hopmeier, P., Haffner, S. M., Schernthaner, G. (1999) Trp64Arg polymorphism of the beta3-adrenergic receptor gene in pregnancy: association with mild gestational diabetes mellitus. J Clin Endocrinol Metab. 84: 16951699.
  • 482
    Fujisawa, T., Ikegami, H., Yamato, E., et al (1996) Association of Trp64Arg mutation of the beta 3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia. 39: 349352.
  • 483
    Higashi, K., Ishikawa, T., Ito, T., Yonemura, A., Shige, H., Nakamura, H. (1997) Association of a genetic variation in the beta 3-adrenergic receptor gene with coronary heart disease among Japanese. Biochem Biophys Res Commun. 232: 728730.
  • 484
    Hoffstedt, J., Poirier, O., Thorne, A., et al (1999) Polymorphism of the human beta(3)-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes. 48: 203205.
  • 485
    Jeyasingam, C., Bryson, J., Caterson, I., Yue, D., Donnelly, R. (1997) Expression of the beta3-adrenoceptor gene polymorphism (Trp64Arg) in obese diabetic and non-diabetic subjects. Clin Exp Pharmacol Physiol. 24: 733735.
  • 486
    Kadowaki, H., Yasuda, K., Iwamoto, K., et al (1995) A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun. 215: 555560.
  • 487
    Kim-Motoyama, H., Yasuda, K., Yamaguchi, T., et al (1997) A mutation of the beta 3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride. Diabetologia. 40: 469472.
  • 488
    Marti, A., Corbalan, M. S., Martinez-Gonzalez, M. A., Martinez, JA. (2002) TRP64ARG polymorphism of the beta3-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle. Diabetes Obes Metab. 4: 428430.
  • 489
    McFarlane-Anderson, N., Bennett, F., Wilks, R., et al (1998) The Trp64Arg mutation of the beta(3)-adrenergic receptor is associated with hyperglycemia and current body mass index in Jamaican women. Metabolism. 47: 617621.
  • 490
    Mitchell, B., Blangero, J., Comuzzie, A., et al (1998) A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican Americans. J Clin Invest. 101: 584587.
  • 491
    Nagase, T., Aoki, A., Yamamoto, M., et al (1997) Lack of association between the Trp64 Arg mutation in the beta 3-adrenergic receptor gene and obesity in Japanese men: a longitudinal analysis. J Clin Endocrinol Metab. 82: 12841287.
  • 492
    Oizumi, T., Daimon, M., Saitoh, T., et al (2001) Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the beta(3)-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample. Diabetes Care. 24: 15791583.
  • 493
    Oksanen, L., Mustajoki, P., Kaprio, J., et al (1996) Polymorphism of the beta 3-adrenergic receptor gene in morbid obesity. Int J Obes Relat Metab Disord. 20: 10551061.
  • 494
    Ongphiphadhanakul, B., Rajatanavin, R., Chanprasertyothin, S., et al (1999) Relation of beta3-adrenergic receptor gene mutation to total body fat but not percent body fat and insulin levels in Thais. Metabolism. 48: 564567.
  • 495
    Sakane, N., Yoshida, T., Umekawa, T., Kondo, M., Sakai, Y., Takahashi, T. (1997) Beta 3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome. Diabetologia. 40: 200204.
  • 496
    Shima, Y., Tsukada, T., Nakanishi, K., Ohta, H. (1998) Association of the Trp64Arg mutation of the beta(3)-adrenergic receptor with fatty liver and mild glucose intolerance in Japanese subjects. Clin Chim Acta. 274: 167176.
  • 497
    Strazzullo, P., Iacone, R., Siani, A., et al (2001) Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens. 19: 399406.
  • 498
    Thomas, G. N., Tomlinson, B., Chan, J. C., Young, R. P., Critchley, JA. (2000) The Trp64Arg polymorphism of the beta3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int J Obes Relat Metab Disord. 24: 545551.
  • 499
    Urhammer, S. A., Clausen, J. O., Hansen, T., Pedersen, O. (1996) Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the beta 3-adrenergic receptor gene. Diabetes. 45: 11151120.
  • 500
    Widen, E., Lehto, M., Kannine, T., Walston, J., Shuldiner, A. R., Groop, LC. (1995) Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med. 333: 348351.
  • 501
    Xinli, W., Xiaomei, T., Meihua, P., Song, L. (2001) Association of a mutation in the beta3-adrenergic receptor gene with obesity and response to dietary intervention in Chinese children. Acta Paediatr. 90: 12331237.
  • 502
    Argyropoulos, G., Rankinen, T., Neufeld, D. R., et al (2002) A polymorphism in the human agouti-related protein is associated with late-onset obesity. J Clin Endocrinol Metab. 87: 41984202.
  • 503
    Chaves, F. J., Giner, V., Corella, D., et al (2002) Body weight changes and the A-6G polymorphism of the angiotensinogen gene. Int J Obes Relat Metab Disord. 26: 11731178.
  • 504
    Hegele, R. A., Brunt, J. H., Connelly, PW. (1995) Genetic variation on chromosome 1 associated with variation in body fat distribution in men. Circulation. 92: 10891093.
  • 505
    Rankinen, T., Gagnon, J., Perusse, L., et al (1999) Body fat, resting and exercise blood pressure and the angiotensinogen M235T polymorphism: the HERITAGE family study. Obes Res. 7: 423430.
  • 506
    Menzaghi, C., Ercolino, T., Di Paola, R., et al (2002) A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes. 51: 23062312.
  • 507
    Stumvoll, M., Tschritter, O., Fritsche, A., et al (2002) Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes. 51: 3741.
  • 508
    Ukkola, O., Ravussin, E., Jacobson, P., Sjöström, L., Bouchard, C. (2003) Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism. 52: 881884.
  • 509
    van't Hooft, F. M., Ruotolo, G., Boquist, S., de Faire, U., Eggertsen, G., Hamsten, A. (2001) Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins. Circulation. 104: 12231228.
  • 510
    Fisher, R. M., Burke, H., Nicaud, V., Ehnholm, C., Humphries, SE. (1999) Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II. J Lipid Res. 40: 287294.
  • 511
    Lefevre, M., Lovejoy, J. C., DeFelice, S. M., et al (2000) Common apolipoprotein A-IV variants are associated with differences in body mass index levels and percentage body fat. Int J Obes Relat Metab Disord. 24: 945953.
  • 512
    Pouliot, M. C., Despres, J. P., Dionne, F. T., et al (1994) Apo B-100 gene EcoR1 polymorphism. Relations to plasma lipoprotein changes associated with abdominal visceral obesity. Arterioscler Thromb. 14: 527533.
  • 513
    Rajput-Williams, J., Wallis, S. C., Yarnell, J., et al (1988) Variation of apolipoprotein-B gene is associated with obesity, high blood cholesterol levels, and increased risk of coronary heart disease. Lancet. 2: 14421446.
  • 514
    Saha, N., Tay, J. S. H., Heng, C. K., Humphries, SE. (1993) DNA polymorphisms of the apolipoprotein B gene are associated with obesity and serum lipids in healthy Indians in Singapore. Clin Genet. 44: 113120.
  • 515
    Vijayaraghavan, S., Hitman, G. A., Kopelman, PG. (1994) Apolipoprotein D polymorphism: a genetic marker of obesity and hyperinsulinemia. J Clin Endocrinol Metab. 79: 568570.
  • 516
    Oh, J. Y., Barrett-Connor, E. (2001) Apolipoprotein E polymorphism and lipid levels differ by gender and family history of diabetes: the Rancho Bernardo Study. Clin Genet. 60: 132137.
  • 517
    Deriaz, O., Dionne, F., Perusse, L., et al (1994) DNA variation in the genes of the Na,K-Adenosine triphosphatase and the its relation with resting metabolic rate, respiratory quotient, and body fat. J Clin Invest. 93: 838843.
  • 518
    Katzmarzyk, P. T., Rankinen, T., Perusse, L., et al (1999) Linkage and association of the sodium potassium-adenosine triphosphatase alpha2 and beta1 genes with respiratory quotient and resting metabolic rate in the Quebec Family Study. J Clin Endocrinol Metab. 84: 20932097.
  • 519
    Hoffstedt, J., Naslund, E., Arner, P. (2002) Calpain-10 gene polymorphism is associated with reduced beta(3)-adrenoceptor function in human fat cells. J Clin Endocrinol Metab. 87: 33623367.
  • 520
    Challis, B. G., Yeo, G. S., Farooqi, I. S., et al (2000) The CART gene and human obesity: mutational analysis and population genetics. Diabetes. 49: 872875.
  • 521
    Yamada, K., Yuan, X., Otabe, S., Koyanagi, A., Koyama, W., Makita, Z. (2002) Sequencing of the putative promoter region of the cocaine- and amphetamine-regulated-transcript gene and identification of polymorphic sites associated with obesity. Int J Obes Relat Metab Disord. 26: 132136.
  • 522
    Wolford, J., Bogardus, C., Prochazka, M. (1998) Polymorphism in the 3′ untranslated region of MTG8 is associated with obesity in Pima Indian males. Biochem Biophys Res Commun. 246: 624626.
  • 523
    Funakoshi, A., Miyasaka, K., Matsumoto, H., et al (2000) Gene structure of human cholecystokinin (CCK) type-A receptor: body fat content is related to CCK type-A receptor gene promoter polymorphism. FEBS Lett. 466: 264266.
  • 524
    Han, Z., Heath, S. C., Shmulewitz, D., et al (2002) Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia. Am J Med Genet. 110: 234242.
  • 525
    Comings, D. E., Flanagan, S. D., Dietz, G., Muhleman, D., Knell, E., Gysin, R. (1993) The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochem Med Metab Biol. 50: 176185.
  • 526
    Spitz, M. R., Detry, M. A., Pillow, P., et al (2000) Variant alleles of the D2 dopamine receptor gene and obesity. Nutr Res. 20: 371380.
  • 527
    Tataranni, P. A., Baier, L., Jenkinson, C., Harper, I., Del Parigi, A., Bogardus, C. (2001) A Ser311Cys mutation in the human dopamine receptor D2 gene is associated with reduced energy expenditure. Diabetes. 50: 901904.
  • 528
    Thomas, G. N., Tomlinson, B., Critchley, JA. (2000) Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism. Hypertension. 36: 177182.
  • 529
    Thomas, G. N., Critchley, J. A., Tomlinson, B., Cockram, C. S., Chan, JC. (2001) Relationships between the taqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol (Oxf). 55: 605611.
  • 530
    Deng, H. W., Li, J., Li, J. L., et al (2000) Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women. J Clin Endocrinol Metab. 85: 27482751.
  • 531
    Speer, G., Cseh, K., Winkler, G., et al (2001) Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol. 144: 385389.
  • 532
    Hegele, R. A., Harris, S. B., Hanley, A. J. G., Sadikian, S., Connelly, P. W., Zinman, B. (1996) Genetic variation of intestinal fatty acid binding protein associated with variation in body mass in Aboriginal Canadians. J Clin Endocrinol Metab. 81: 43344337.
  • 533
    Yamada, K., Yuan, X., Ishiyama, S., et al (1997) Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia. 40: 706710.
  • 534
    Siani, A., Iacone, R., Russo, O., et al (2001) Gly40Ser polymorphism of the glucagon receptor gene is associated with central adiposity in men. Obes Res. 9: 722726.
  • 535
    Hattersley, A. T., Beards, F., Ballantyne, E., Appleton, M., Harvey, R., Ellard, S. (1998) Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet. 19: 268270.
  • 536
    Korbonits, M., Gueorguiev, M., O'Grady, E., et al (2002) A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children. J Clin Endocrinol Metab. 87: 40054008.
  • 537
    Ukkola, O., Ravussin, E., Jacobson, P., et al (2001) Mutations in the preproghrelin/ghrelin gene associated with obesity in humans. J Clin Endocrinol Metab. 86: 39963999.
  • 538
    Gutersohn, A., Naber, C., Muller, N., Erbel, R., Siffert, W. (2000) G protein beta3 subunit 825 TT genotype and post-pregnancy weight retention. Lancet. 355: 12401241.
  • 539
    Hauner, H., Rohrig, K., Siffert, W. (2002) Effects of the G-Protein beta3 subunit 825T allele on adipogenesis and lipolysis in cultured human preadipocytes and adipocytes. Horm Metab Res. 34: 475480.
  • 540
    Hegele, R. A., Anderson, C., Young, T. K., Connelly, PW. (1999) G-protein beta3 subunit gene splice variant and body fat distribution in nunavut inuit. Genome Res. 9: 972977.
  • 541
    Hocher, B., Slowinski, T., Stolze, T., Pleschka, A., Neumayer, H. H., Halle, H. (2000) Association of maternal G protein beta3 subunit 825T allele with low birthweight. Lancet. 355: 12411242.
  • 542
    Poch, E., Giner, V., Gonzalez-Nunez, D., Coll, E., Oriola, J., de la Sierra, A. (2002) Association of the G protein beta3 subunit T allele with insulin resistance in essential hypertension. Clin Exp Hypertens. 24: 345353.
  • 543
    Rankinen, T., Rice, T., Leon, A. S., et al (2002) G protein beta 3 polymorphism and hemodynamic and body composition phenotypes in the HERITAGE Family Study. Physiol Genomics. 8: 151157.
  • 544
    Ryden, M., Faulds, G., Hoffstedt, J., Wennlund, A., Arner, P. (2002) Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes. 51: 16011608.
  • 545
    Siffert, W., Naber, C., Walla, M., Ritz, E. (1999) G protein beta 3 subunit 825T allele and its potential association with obesity in hypertensive individuals. J Hypertens. 17: 10951098.
  • 546
    Siffert, W., Forster, P., Jockel, K., et al (1999) Worldwide ethnic distribution of the G protein beta 3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol. 10: 19211930.
  • 547
    Orho-Melander, M., Almgren, P., Kanninen, T., Forsblom, C., Groop, L. (1999) A paired-sibling analysis of the Xbal polymorphism in the muscle glycogen synthase gene. Diabetologia. 42: 11381145.
  • 548
    Vohl, M. C., Dionne, F., Perusse, L., Deriaz, O., Chagnon, M., Bouchard, C. (1994) Relation between Bg1II polymorphism in 3β-hydroxysteroid dehydrogenase gene and adipose tissue distribution in humans. Obes Res. 2: 444449.
  • 549
    Chouchane, L., Danguir, J., Beji, C., et al (2001) Genetic variation in the stress protein hsp70–2 gene is highly associated with obesity. Int J Obes Relat Metab Disord. 25: 462466.
  • 550
    Levitan, R. D., Kaplan, A. S., Masellis, M., et al (2001) Polymorphism of the serotonin 5-HT1B receptor gene (HTR1B) associated with minimum lifetime body mass index in women with bulimia nervosa. Biol Psychiatry. 50: 640643.
  • 551
    Aubert, R., Betoulle, D., Herbeth, B., Siest, G., Fumeron, F. (2000) 5-HT2A receptor gene polymorphism is associated with food and alcohol intake in obese people. Int J Obes Relat Metab Disord. 24: 920924.
  • 552
    Rosmond, R., Bouchard, C., Björntorp, P. (2002) 5-HT(2A) receptor gene promoter polymorphism in relation to abdominal obesity and cortisol. Obes Res. 10: 585589.
  • 553
    Reynolds, G. P., Zhang, Z. J., Zhang, XB. (2002) Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet. 359: 20862087.
  • 554
    Westberg, L., Bah, J., Rastam, M., et al (2002) Association between a polymorphism of the 5-HT2C receptor and weight loss in teenage girls. Neuropsychopharmacology. 26: 789793.
  • 555
    Yuan, X., Yamada, K., Ishiyama-Shigemoto, S., Koyama, W., Nonaka, K. (2000) Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes. Diabetologia. 43: 373376.
  • 556
    Sun, G., Gagnon, J., Chagnon, Y., et al (1999) Association and linkage between an insulin-like growth factor-1 gene polymorphism and fat free mass in the HERITAGE family study. Int J Obes Relat Metab Disord. 23: 929935.
  • 557
    O'Dell, S. D., Miller, G. J., Cooper, J. A., et al (1997) Apa1 polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. Int J Obes Relat Metab Disord. 21: 822825.
  • 558
    Roth, S. M., Schrager, M. A., Metter, E. J., et al (2002) IGF2 genotype and obesity in men and women across the adult age span. Int J Obes Relat Metab Disord. 26: 585587.
  • 559
    Dunger, D. B., Ong, K. K. L., Huxtable, S. J., et al (1998) Association of the INS VNTR with size at birth. Nat Genet. 19: 98100.
  • 560
    Gu, D., O'Dell, S. D., Chen, X. H., Miller, G. J., Day, IN. (2002) Evidence of multiple causal sites affecting weight in the IGF2-INS-TH region of human chromosome 11. Hum Genet. 110: 173181.
  • 561
    Le Stunff, C., Fallin, D., Bougneres, P. (2001) Paternal transmission of the very common class I INS VNTR alleles predisposes to childhood obesity. Nat Genet. 29: 9699.
  • 562
    O'Dell, S. D., Bujac, S. R., Miller, G. J., Day, IN. (1999) Associations of IGF2 ApaI RFLP and INS VNTR class I allele size with obesity. Eur J Hum Genet. 7: 821827.
  • 563
    Weaver, J. U., Kopelman, P. G., Hitman, GA. (1992) Central obesity and hyperinsulinaemia in women are associated with polymorhism in the 5′ flanking region of the human insulin gene. Eur J Clin Invest. 22: 265270.
  • 564
    Zee, R. Y., Lou, Y. K., Morris, BJ. (1994) Insertion variant in intron 9, but not microsatellite in intron 2, of the insulin receptor gene is associated with essential hypertension. J Hypertens Suppl. 12: 1322.
  • 565
    Krempler, F., Hell, E., Winkler, C., Breban, D., Patsch, W. (1998) Plasma leptin levels: interaction of obesity with a common variant of insulin receptor substrate-1. Arterioscler Thromb Vasc Biol. 18: 16861690.
  • 566
    Lei, H., Coresh, J., Shuldiner, A., Boerwinkle, E., Brancati, F. (1999) Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes. 48: 18681872.
  • 567
    Griffiths, L. R., Nyhold, D. R., Curtain, R. P., Gaffney, P. T., Morris, BJ. (1995) Cross-sectional study of a microsatellite marker in the low density lipoprotein receptor gene in obese normotensives. Clin Exp Pharmacol Physiol. 22: 496498.
  • 568
    Mattevi, V. S., Coimbra, C. E., Santos, R. V., Salzano, F. M., Hutz, MH. (2000) Association of the low-density lipoprotein receptor gene with obesity in Native American populations. Hum Genet. 106: 546552.
  • 569
    Rutherford, S., Nyholt, D., Curtain, R., et al (1997) Association of a low density lipoprotein receptor microsatellite variant with obesity. Int J Obes Relat Metab Disord. 21: 10321037.
  • 570
    Zee, R. Y. L., Griffiths, L. R., Morris, BJ. (1992) Marked association of a RFLP for the low density lipoprotein receptor gene with obesity in essential hypertensives. Biochem Biophys Res Commun. 189: 965971.
  • 571
    Zee, R. Y. L., Schrader, A. P., Robinson, B. G., Griffiths, L. R., Morris, BJ. (1995) Association of HincII RFLP of low density lipoprotein receptor gene with obesity in essential hypertensives. Clin Genet. 47: 118121.
  • 572
    Butler, M. G., Hedges, L., Hovis, C. L., Feurer, ID. (1998) Genetic variants of the human obesity (OB) gene in subjects with and without Prader-Willi syndrome: comparison with body mass index and weight. Clin Genet. 54: 385393.
  • 573
    Hager, J., Clement, K., Francke, S., et al (1998) A polymorphism in the 5′ untranslated region of the human ob gene is associated with low leptin levels. Int J Obes Relat Metab Disord. 22: 200205.
  • 574
    Hoffstedt, J., Eriksson, P., Mottagui-Tabar, S., Arner, P. (2002) A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res. 34: 355359.
  • 575
    Le Stunff, C., Le Bihan, C., Schork, N. J., Bougneres, P. (2000) A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls. Diabetes. 49: 21962200.
  • 576
    Li, W. D., Reed, D. R., Lee, J. H., et al (1999) Sequence variants in the 5′ flanking region of the leptin gene are associated with obesity in women. Ann Hum Genet. 63: 227234.
  • 577
    Mammes, O., Betoulle, D., Aubert, R., et al (1998) Novel polymorphisms in the 5′ region of the LEP gene: association with leptin levels and response to low-calorie diet in human obesity. Diabetes. 47: 487489.
  • 578
    Oksanen, L., Ohman, M., Heiman, M., et al (1997) Markers for the gene ob and serum leptin levels in human morbid obesity. Hum Genet. 99: 559564.
  • 579
    Shintani, M., Ikegami, H., Yamato, E., et al (1996) A novel microsatellite polymorphism in the human OB gene: a highly polymorphic marker for linkage analysis. Diabetologia. 39: 13981401.
  • 580
    Chagnon, Y. C., Wilmore, J. H., Borecki, I. B., et al (2000) Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family study. J Clin Endocrinol Metab. 85: 2934.
  • 581
    Chagnon, Y. C., Chung, W. K., Perusse, L., Chagnon, M., Leibel, R. L., Bouchard, C. (1999) Linkages and associations between the leptin receptor (LEPR) gene and human body composition in the Quebec Family Study. Int J Obes Relat Metab Disord. 23: 278286.
  • 582
    da Silva, B., Gapstur, S. M., Achenbach, Y. H., et al (2000) Lack of association between the −308 polymorphism of the tumor necrosis factor-alpha gene and the insulin resistance syndrome. J Investig Med. 48: 236244.
  • 583
    Mammes, O., Aubert, R., Betoulle, D., et al (2001) LEPR gene polymorphisms: associations with overweight, fat mass and response to diet in women. Eur J Clin Invest. 31: 398404.
  • 584
    Mattevi, V. S., Zembrzuski, V. M., Hutz, MH. (2002) Association analysis of genes involved in the leptin-signaling pathway with obesity in Brazil. Int J Obes Relat Metab Disord. 26: 11791185.
  • 585
    Quinton, N. D., Lee, A. J., Ross, R. J., Eastell, R., Blakemore, AI. (2001) A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet. 108: 233236.
  • 586
    Rosmond, R., Chagnon, Y. C., Holm, G., et al (2000) Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab. 85: 31263131.
  • 587
    Roth, H., Korn, T., Rosenkranz, K., et al (1998) Transmission disequilibrium and sequence variants at the leptin receptor gene in extremely obese German children and adolescents. Hum Genet. 103: 540546.
  • 588
    Thompson, D. B., Ravussin, E., Bennett, P. H., Bogardus, C. (1997) Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum Mol Genet. 6: 675679.
  • 589
    Wauters, M., Mertens, I., Chagnon, M., et al (2001) Polymorphisms in the leptin receptor gene, body composition and fat distribution in overweight and obese women. Int J Obes Relat Metab Disord. 25: 714720.
  • 590
    Yiannakouris, N., Yannakoulia, M., Melistas, L., Chan, J. L., Klimis-Zacas, D., Mantzoros, CS. (2001) The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab. 86: 44344439.
  • 591
    Garenc, C., Perusse, L., Chagnon, Y. C., et al (2002) The hormone-sensitive lipase gene and body composition: the HERITAGE Family Study. Int J Obes Relat Metab Disord. 26: 220227.
  • 592
    Hoffstedt, J., Arner, P., Schalling, M., et al (2001) A common hormone-sensitive lipase i6 gene polymorphism is associated with decreased human adipocyte lipolytic function. Diabetes. 50: 24102413.
  • 593
    Lavebratt, C., Ryden, M., Schalling, M., Sengul, S., Ahlberg, S., Hoffstedt, J. (2002) The hormone-sensitive lipase i6 gene polymorphism and body fat accumulation. Eur J Clin Invest. 32: 938942.
  • 594
    Magre, J., Laurell, H., Fizames, C., et al (1998) Human hormone-sensitive lipase. Genetic mapping, identification of a new dinucleotide repeat, and association with obesity and NIDDM. Diabetes. 47: 284286.
  • 595
    Pihlajamaki, J., Valve, R., Karjalainen, L., Karhapaa, P., Vauhkonen, I., Laakso, M. (2001) The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance. Eur J Clin Invest. 31: 302308.
  • 596
    Hegele, R. A., Cao, H., Huff, M. W., Anderson, CM. (2000) LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration. J Clin Endocrinol Metab. 85: 30893093.
  • 597
    Hegele, R. A., Cao, H., Harris, S. B., Zinman, B., Hanley, A. J., Anderson, CM. (2000) Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal canadians. Physiol Genomics. 3: 3944.
  • 598
    Hegele, R. A., Anderson, C. M., Wang, J., Jones, D. C., Cao, H. (2000) Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res. 10: 652658.
  • 599
    Hegele, R. A., Huff, M. W., Young, TK. (2001) Common genomic variation in LMNA modulates indexes of obesity in Inuit. J Clin Endocrinol Metab. 86: 27472751.
  • 600
    Garenc, C., Perusse, L., Bergeron, J., et al (2001) Evidence of LPL gene-exercise interaction for body fat and LPL activity: the HERITAGE Family Study. J Appl Physiol. 91: 13341340.
  • 601
    Jemaa, R., Tuzet, S., Portos, C., Betoulle, D., Apfelbaum, M., Fumeron, F. (1995) Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes Relat Metab Disord. 19: 270274.
  • 602
    Boucher, N., Lanouette, C. M., Larose, M., Perusse, L., Bouchard, C., Chagnon, YC. (2002) A +2138InsCAGACC polymorphism of the melanocortin receptor 3 gene is associated in human with fat level and partitioning in interaction with body corpulence. Mol Med. 8: 158165.
  • 603
    Chagnon, Y. C., Chen, W. J., Perusse, L., et al (1997) Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Quebec Family Study. Mol Med. 3: 663673.
  • 604
    Rosmond, R., Chagnon, M., Bouchard, C., Björntorp, P. (2001) A missense mutation in the human melanocortin-4 receptor gene in relation to abdominal obesity and salivary cortisol. Diabetologia. 44: 13351338.
  • 605
    Bray, M. S., Boerwinkle, E., Hanis, CL. (2000) Sequence variation within the neuropeptide Y gene and obesity in Mexican Americans. Obes Res. 8: 219226.
  • 606
    Karvonen, M. K., Koulu, M., Pesonen, U., et al (2000) Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children. J Clin Endocrinol Metab. 85: 14551460.
  • 607
    Jenkinson, C. P., Cray, K., Walder, K., Herzog, H., Ravussin, E., Hanson, R. (2000) Novel polymorphisms in the neuropeptide-Y Y5 receptor associated with obesity in Pima Indians. Int J Obes Relat Metab Disord. 24: 580584.
  • 608
    Nishigori, H., Tomura, H., Tonooka, N., et al (2001) Mutations in the small heterodimer partner gene are associated with mild obesity in Japanese subjects. Proc Natl Acad Sci U S A. 98: 575580.
  • 609
    Buemann, B., Vohl, M. C., Chagnon, M., et al (1997) Abdominal visceral fat is associated with a BclI restriction fragment length polymorphism at the glucocorticoid receptor gene locus. Obes Res. 5: 186192.
  • 610
    Dobson, M. G., Redfern, C. P., Unwin, N., Weaver, JU. (2001) The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J Clin Endocrinol Metab. 86: 22702274.
  • 611
    Rosmond, R., Chagnon, Y. C., Holm, G., et al (2000) A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes Res. 8: 211218.
  • 612
    Ukkola, O., Perusse, L., Chagnon, Y. C., Despres, J. P., Bouchard, C. (2001) Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Quebec Family Study. Int J Obes Relat Metab Disord. 25: 13321339.
  • 613
    Ukkola, O., Rosmond, R., Tremblay, A., Bouchard, C. (2001) Glucocorticoid receptor Bcl I variant is associated with an increased atherogenic profile in response to long-term overfeeding. Atherosclerosis. 157: 221224.
  • 614
    del Giudice, E. M., Cirillo, G., Santoro, N., et al (2001) Molecular screening of the proopiomelanocortin (POMC) gene in Italian obese children: report of three new mutations. Int J Obes Relat Metab Disord. 25: 6167.
  • 615
    Hixson, J., Almasy, L., Cole, S., et al (1999) Normal variation in leptin levels is associated with polymorphisms in the proopiomelanocortin gene, POMC. J Clin Endocrinol Metab. 84: 31873191.
  • 616
    Busch, C., Ramdath, D., Ramsewak, S., Hegele, R. (1999) Association of PON2 variation with birth weight in Trinidadian neonates of South Asian ancestry. Pharmacogenetics. 9: 351356.
  • 617
    Evans, D., Aberle, J., Wendt, D., Wolf, A., Beisiegel, U., Mann, WA. (2001) A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus. J Mol Med. 79: 198204.
  • 618
    Cole, S. A., Mitchell, B. D., Hsueh, W. C., et al (2000) The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans. Int J Obes Relat Metab Disord. 24: 522524.
  • 619
    Deeb, S. S., Fajas, L., Nemoto, M., et al (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 20: 284287.
  • 620
    Ek, J., Urhammer, S. A., Sorensen, T. I., Andersen, T., Auwerx, J., Pedersen, O. (1999) Homozygosity of the Pro12Ala variant of the peroxisome proliferation- activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia. 42: 892895.
  • 621
    Gonzalez Sanchez J. L., Serrano Rios M., Fernandez Perez C., Laakso, M., Martinez Larrad MT. (2002) Effect of the Pro12Ala polymorphism of the peroxisome proliferator- activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur J Endocrinol. 147: 495501.
  • 622
    Hasstedt, S. J., Ren, Q. F., Teng, K., Elbein, SC. (2001) Effect of the peroxisome proliferator-activated receptor-gamma 2 pro(12)ala variant on obesity, glucose homeostasis, and blood pressure in members of familial type 2 diabetic kindreds. J Clin Endocrinol Metab. 86: 536541.
  • 623
    Lindi, V., Sivenius, K., Niskanen, L., Laakso, M., Uusitupa, MI. (2001) Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on long-term weight change in Finnish non-diabetic subjects. Diabetologia. 44: 925926.
  • 624
    Lindi, V. I., Uusitupa, M. I., Lindstrom, J., et al (2002) Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes. 51: 25812586.
  • 625
    Meirhaeghe, A., Fajas, L., Helbecque, N., et al (2000) Impact of the peroxisome proliferator activated receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord. 24: 195199.
  • 626
    Meirhaeghe, A., Fajas, L., Helbecque, N., et al (1998) A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet. 7: 435440.
  • 627
    Nicklas, B. J., van Rossum, E. F., Berman, D. M., Ryan, A. S., Dennis, K. E., Shuldiner, AR. (2001) Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes. 50: 21722176.
  • 628
    Ristow, M., Muller-Wieland, D., Pfeiffer, A., Krone, W., Kahn, CR. (1998) Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med. 339: 953959.
  • 629
    Vaccaro, O., Mancini, F. P., Ruffa, G., Sabatino, L., Colantuoni, V., Riccardi, G. (2000) Pro12Ala mutation in the peroxisome proliferator-activated receptor gamma2 (PPARgamma2) and severe obesity: a case-control study. Int J Obes Relat Metab Disord. 24: 11951199.
  • 630
    Valve, R., Sivenius, K., Miettinen, R., et al (1999) Two polymorphisms in the peroxisome proliferator-activated receptor- gamma gene are associated with severe overweight among obese women. J Clin Endocrinol Metab. 84: 37083712.
  • 631
    Esterbauer, H., Oberkofler, H., Linnemayr, V., et al (2002) Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with obesity indices in middle-aged women. Diabetes. 51: 12811286.
  • 632
    Engert, J. C., Vohl, M. C., Williams, S. M., et al (2002) 5′ flanking variants of resistin are associated with obesity. Diabetes. 51: 16291634.
  • 633
    Iwai, N., Katsuya, T., Mannami, T., et al (2002) Association between SAH, an acyl-CoA synthetase gene, and hypertriglyceridemia, obesity, and hypertension. Circulation. 105: 4147.
  • 634
    Acton, S., Osgood, D., Donoghue, M., et al (1999) Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol. 19: 17341743.
  • 635
    Hoffstedt, J., Andersson, I. L., Persson, L., Isaksson, B., Arner, P. (2002) The common −675 4G/5G polymorphism in the plasminogen activator inhibitor −1 gene is strongly associated with obesity. Diabetologia. 45: 584587.
  • 636
    Lin, W. H., Chiu, K. C., Chang, H. M., Lee, K. C., Tai, T. Y., Chuang, LM. (2001) Molecular scanning of the human sorbin and SH3-domain-containing-1 (SORBS1) gene: positive association of the T228A polymorphism with obesity and type 2 diabetes. Hum Mol Genet. 10: 17531760.
  • 637
    Brand, E., Schorr, U., Kunz, I., et al (2001) Tumor necrosis factor-alpha-308 G/A polymorphism in obese Caucasians. Int J Obes Relat Metab Disord. 25: 581585.
  • 638
    Dalziel, B., Gosby, A. K., Richman, R. M., Bryson, J. M., Caterson, ID. (2002) Association of the TNF-alpha −308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res. 10: 401407.
  • 639
    Fernandez-Real, J. M., Gutierrez, C., Ricart, W., et al (1997) The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes. 46: 14681472.
  • 640
    Herrmann, S., Ricard, S., Nicaud, V., et al (1998) Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest. 28: 5966.
  • 641
    Hoffstedt, J., Eriksson, P., Hellstrom, L., Rossner, S., Ryden, M., Arner, P. (2000) Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men. Diabetologia. 43: 117120.
  • 642
    Kamizono, S., Yamada, K., Seki, N., et al (2000) Susceptible locus for obese type 2 diabetes mellitus in the 5′-flanking region of the tumor necrosis factor-alpha gene. Tissue Antigens. 55: 449452.
  • 643
    Norman, R. A., Bogardus, C., Ravussin, E. (1995) Linkage between obesity and a marker near the tumor necrosis factor-A locus in Pima Indians. J Clin Invest. 96: 158162.
  • 644
    Pausova, Z., Deslauriers, B., Gaudet, D., et al (2000) Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians. Hypertension. 36: 1419.
  • 645
    Fernandez-Real, J. M., Vendrell, J., Ricart, W., et al (2000) Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care. 23: 831837.
  • 646
    Philibert, R., Caspers, K., Langbehn, D., et al (2002) The association of a HOPA polymorphism with major depression and phobia. Compr Psychiatry. 43: 404410.
  • 647
    Fumeron, F., Durack-Bown, I., Betoulle, D., et al (1996) Polymorphisms of uncoupling protein (UCP) and beta 3 adrenoreceptor genes in obese people submitted to a low calorie diet. Int J Obes Relat Metab Disord. 20: 10511054.
  • 648
    Heilbronn, L. K., Kind, K. L., Pancewicz, E., Morris, A. M., Noakes, M., Clifton, PM. (2000) Association of −3826 G variant in uncoupling protein-1 with increased BMI in overweight Australian women. Diabetologia. 43: 242244.
  • 649
    Kogure, A., Yoshida, T., Sakane, N., Umekawa, T., Takakura, Y., Kondo, M. (1998) Synergic effect of polymorphisms in uncoupling protein 1 and beta3- adrenergic receptor genes on weight loss in obese Japanese. Diabetologia. 41: 1399
  • 650
    Oppert, J. M., Vohl, M. C., Chagnon, M., et al (1994) DNA polymorphism in the uncoupling protein (UCP) gene and human body fat. Int J Obes Relat Metab Disord. 18: 526531.
  • 651
    Ukkola, O., Tremblay, A., Sun, G., Chagnon, Y. C., Bouchard, C. (2001) Genetic variation at the uncoupling protein 1, 2 and 3 loci and the response to long-term overfeeding. Eur J Clin Nutr. 55: 10081015.
  • 652
    Astrup, A., Toubro, S., Dalgaard, L. T., Urhammer, S. A., Sorensen, T. I. A., Pedersen, O. (1999) Impact of the v/v 55 polymorphism of the uncoupling protein 2 gene on 24-h energy expenditure and substrate oxidation. Int J Obes Relat Metab Disord. 23: 10301034.
  • 653
    Cassell, P. G., Neverova, M., Janmohamed, S., et al (1999) An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes. Diabetologia. 42: 688692.
  • 654
    Esterbauer, H., Schneitler, C., Oberkofler, H., et al (2001) A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet. 28: 178183.
  • 655
    Evans, D., Minouchehr, S., Hagemann, G., et al (2000) Frequency of and interaction between polymorphisms in the beta3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans. Int J Obes Relat Metab Disord. 24: 12391245.
  • 656
    Evans, D., Wolf, A. M., Nellessen, U., et al (2001) Association between polymorphisms in candidate genes and morbid obesity. Int J Obes Relat Metab Disord. 25: S19S21.
  • 657
    Nordfors, L., Heimburger, O., Lonnqvist, F., et al (2000) Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. Kidney Int. 57: 17131719.
  • 658
    Walder, K., Norman, R., Hanson, R., et al (1998) Association between uncoupling protein polymorphisms (UCP2-UCP3) and energy metabolism obesity in Pima Indians. Hum Mol Genet. 7: 14311435.
  • 659
    Yanovski, J. A., Diament, A. L., Sovik, K. N., et al (2000) Associations between uncoupling protein 2, body composition, and resting energy expenditure in lean and obese African American, white, and Asian children. Am J Clin Nutr. 71: 14051420.
  • 660
    Argyropoulos, G., Brown, A. M., Willi, S. M., et al (1998) Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J Clin Invest. 102: 13451351.
  • 661
    Cassell, P. G., Saker, P. J., Huxtable, S. J., et al (2000) Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin. Diabetologia. 43: 15581564.
  • 662
    Halsall, D., Luan, J., Saker, P., et al (2001) Uncoupling protein 3 genetic variants in human obesity: the c-55t promoter polymorphism is negatively correlated with body mass index in a UK Caucasian population. Int J Obes Relat Metab Disord. 25: 472477.
  • 663
    Kimm, S. Y., Glynn, N. W., Aston, C. E., et al (2002) Racial differences in the relation between uncoupling protein genes and resting energy expenditure. Am J Clin Nutr. 75: 714719.
  • 664
    Lanouette, C. M., Giacobino, J. P., Perusse, L., et al (2001) Association between uncoupling protein 3 gene and obesity-related phenotypes in the Quebec Family Study. Mol Med. 7: 433441.
  • 665
    Lanouette, C. M., Chagnon, Y. C., Rice, T., et al (2002) Uncoupling protein 3 gene is associated with body composition changes with training in HERITAGE study. J Appl Physiol. 92: 11111118.
  • 666
    Otabe, S., Clement, K., Dina, C., et al (2000) A genetic variation in the 5′ flanking region of the UCP3 gene is associated with body mass index in humans in interaction with physical activity. Diabetologia. 43: 245249.
  • 667
    Otabe, S., Clement, K., Dubois, S., et al (1999) Mutation screening and association studies of the human uncoupling protein 3 gene in normoglycemic and diabetic morbidly obese patients. Diabetes. 48: 206208.
  • 668
    Yanagisawa, Y., Hasegawa, K., Dever, G. J., et al (2001) Uncoupling protein 3 and peroxisome proliferator-activated receptor gamma2 contribute to obesity and diabetes in palauans. Biochem Biophys Res Commun. 281: 772778.
  • 669
    Deng, H. W., Deng, H., Liu, Y. J., et al (2002) A genomewide linkage scan for quantitative-trait loci for obesity phenotypes. Am J Hum Genet. 70: 11381151.
  • 670
    Stone, S., Abkevich, V., Hunt, S. C., et al (2002) A major predisposition locus for severe obesity, at 4p15–p14. Am J Hum Genet. 70: 14591468.
  • 671
    Wilson, A. F., Elston, R. C., Tran, L. D., Siervogel, RM. (1991) Use of the robust sib-pair method to screen for single-locus, multiple-locus, and pleiotropic effects: application to traits related to hypertension. Am J Hum Genet. 48: 862872.
  • 672
    Chagnon, Y. C., Perusse, L., Lamothe, M., et al (1997) Suggestive linkages between markers on human 1p32–p22 and body fat and insulin levels in the Quebec Family Study. Obes Res. 5: 115121.
  • 673
    Bray, M. S., Boerwinkle, E., Hanis, CL. (1999) Linkage analysis of candidate obesity genes among the Mexican-American population of Starr County, Texas. Genet Epidemiol. 16: 397411.
  • 674
    van der Kallen, C. J., Cantor, R. M., van Greevenbroek, M. M., et al (2000) Genome scan for adiposity in Dutch dyslipidemic families reveals novel quantitative trait loci for leptin, body mass index and soluble tumor necrosis factor receptor superfamily 1A. Int J Obes Relat Metab Disord. 24: 13811391.
  • 675
    Norman, R., Tataranni, P., Pratley, R., et al (1998) Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. Am J Hum Genet. 62: 659668.
  • 676
    Perusse, L., Rice, T., Chagnon, Y., et al (2001) A genome-wide scan for abdominal fat assessed by computed tomography in the Quebec Family Study. Diabetes. 50: 614621.
  • 677
    Feitosa, M. F., Borecki, I. B., Rich, S. S., et al (2002) Quantitative-trait loci influencing body-mass index reside on chromosomes 7 and 13: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet. 70: 7282.
  • 678
    Weyer, C., Wolford, J. K., Hanson, R. L., et al (2001) Subcutaneous abdominal adipocyte size, a predictor of type 2 diabetes, is linked to chromosome 1q21–q23 and is associated with a common polymorphism in LMNA in Pima Indians. Mol Genet Metab. 72: 231238.
  • 679
    Bailey-Wilson, J. E., Wilson, A. F., Bamba, V. (1993) Linkage analysis in a large pedigree ascertained due to essential familial hypercholesterolemia. Genet Epidemiol. 10: 665669.
  • 680
    Delplanque, J., Barat-Houari, M., Dina, C., et al (2000) Linkage and association studies between the proopiomelanocortin (POMC) gene and obesity in caucasian families. Diabetologia. 43: 15541557.
  • 681
    Comuzzie, A. G., Funahashi, T., Sonnenberg, G., et al (2001) The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab. 86: 43214325.
  • 682
    Rotimi, C. N., Comuzzie, A. G., Lowe, W. L., Luke, A., Blangero, J., Cooper, RS. (1999) The quantitative trait locus on chromosome 2 for serum leptin levels is confirmed in African-Americans. Diabetes. 48: 643644.
  • 683
    Rice, T., Chagnon, Y. C., Perusse, L., et al (2002) A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: The HERITAGE Family Study. Diabetes. 51: 848855.
  • 684
    Wu, X., Cooper, R. S., Borecki, I., et al (2002) A combined analysis of genomewide linkage scans for body mass index from the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am J Hum Genet. 70: 12471256.
  • 685
    Norman, R. A., Thompson, D. B., Foroud, T., et al (1997) Genome wide search for genes influencing percent body fat in Pima Indians: suggestive linkage at chromosome 11q21–q22. Am J Hum Genet. 60: 166173.
  • 686
    Zhu, X., Cooper, R. S., Luke, A., et al (2002) A genome-wide scan for obesity in African-Americans. Diabetes. 51: 541544.
  • 687
    Borecki, I. B., Rice, T., Pérusse, L., Bouchard, C., Rao, DC. (1994) An exploratory investigation of genetic linkage with obesity phenotypes: the Quebec Family Study. Obes Res. 2: 213219.
  • 688
    Lindsay, R. S., Kobes, S., Knowler, W. C., Bennett, P. H., Hanson, RL. (2001) Genome-wide linkage analysis assessing parent-of-origin effects in the inheritance of type 2 diabetes and BMI in Pima Indians. Diabetes. 50: 28502857.
  • 689
    Clement, K., Dina, C., Basdevant, A., et al (1999) A sib-pair analysis study of 15 candidate genes in French families with morbid obesity: indication for linkage with islet 1 locus on chromosome 5q. Diabetes. 48: 398402.
  • 690
    Steinle, N. I., Hsueh, W. C., Snitker, S., et al (2002) Eating behavior in the Old Order Amish: heritability analysis and a genome-wide linkage analysis. Am J Clin Nutr. 75: 10981106.
  • 691
    Walder, K., Morris, C., Ravussin, E. (2000) A polymorphism in the gene encoding CART is not associated with obesity in Pima Indians. Int J Obes Relat Metab Disord. 24: 520521.
  • 692
    Arya, R., Blangero, J., Williams, K., et al (2002) Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes. 51: 841847.
  • 693
    Chagnon, Y. C., Borecki, I. B., Perusse, L., et al (2000) Genome-wide search for genes related to the fat-free body mass in the Quebec family study. Metabolism. 49: 203207.
  • 694
    Clement, K., Garner, C., Hager, J., et al (1996) Indication for linkage of the human OB gene region with extreme obesity. Diabetes. 45: 687690.
  • 695
    Duggirala, R., Stern, M. P., Mitchell, B. D., et al (1996) Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7. Am J Hum Genet. 59: 694703.
  • 696
    Onions, K., Hunt, S., Rutkowski, M., et al (1998) Genetic markers at the leptin (OB) locus are not significantly linked to hypertension in African Americans. Hypertension. 31: 12301234.
  • 697
    Reed, D. R., Ding, Y., Xu, W., Cather, C., Green, E. D., Price, RA. (1996) Extreme obesity may be linked to markers flanking the human OB gene. Diabetes. 45: 691694.
  • 698
    Roth, H., Hinney, A., Ziegler, A., et al (1997) Further support for linkage of extreme obesity to the obese gene in a study group of obese children and adolescents. Exp Clin Endocrinol Diabetes. 105: 341344.
  • 699
    Lapsys, N. M., Furler, S. M., Moore, K. R., et al (1997) Relationship of a novel polymorphic marker near the human obese (OB) gene to fat mass in healthy women. Obes Res. 5: 430433.
  • 700
    Hsueh, W. C., Mitchell, B. D., Schneider, J. L., et al (2001) Genome-wide scan of obesity in the Old Order Amish. J Clin Endocrinol Metab. 86: 11991205.
  • 701
    Mitchell, B., Cole, S., Comuzzie, A., et al (1999) A quantitative trait locus influencing BMI maps to the region of the beta-3 adrenergic receptor. Diabetes. 48: 18631867.
  • 702
    Chagnon, Y. C., Rice, T., Perusse, L., et al (2001) Genomic scan for genes affecting body composition before and after training in Caucasians from HERITAGE. J Appl Physiol. 90: 17771787.
  • 703
    Hinney, A., Ziegler, A., Oeffner, F., et al (2000) Independent confirmation of a major locus for obesity on chromosome 10. J Clin Endocrinol Metab. 85: 29622965.
  • 704
    Price, R. A., Li, W. D., Bernstein, A., et al (2001) A locus affecting obesity in human chromosome region 10p12. Diabetologia. 44: 363366.
  • 705
    Bouchard, C., Perusse, L., Chagnon, Y. C., Warden, C., Ricquier, D. (1997) Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans. Hum Mol Genet. 6: 18871889.
  • 706
    Hanson, R. L., Ehm, M. G., Pettitt, D. J., et al (1998) An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet. 63: 11301138.
  • 707
    Ohman, M., Oksanen, L., Kaprio, J., et al (2000) Genome-wide scan of obesity in Finnish sibpairs reveals linkage to chromosome Xq24. J Clin Endocrinol Metab. 85: 31833190.
  • 708
    Hunt, S. C., Abkevich, V., Hensel, C. H., et al (2001) Linkage of body mass index to chromosome 20 in Utah pedigrees. Hum Genet. 109: 279285.
  • 709
    Lee, J. H., Reed, D. R., Li, W. D., et al (1999) Genome scan for human obesity and linkage to markers in 20q13. Am J Hum Genet. 64: 196209.
  • 710
    Price, R. A., Kilker, R., Li, WD. (2002) An X-chromosome scan reveals a locus for fat distribution in chromosome region Xp21–22. Diabetes. 51: 19891991.